American College of Clinical Pharmacy
      Search      Cart
         

Continuing Pharmacy Education (CPE) Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). The 2022 ACCP Global Conference on Clinical Pharmacy will provide up to 22.75 contact hours of CPE credit. To receive CPE for Global Conference sessions, each attendee must claim the relevant CPE hours at www.accp.com/ce within 60 days of the session. Statements of credit will be available at CPE Monitor within 2–3 business days.

To receive BCACP, BCCCP, BCGP, BCOP, or BCPS recertification credit for a recertification related program offered at the 2022 Global Conference on Clinical Pharmacy, each attendee must purchase the recertification posttest and submit a passing score on the posttest by the deadline listed in the session materials. The posttest will be made available on the "My Account" page of the ACCP website on the published date in the session materials.

Target Audience

The ACCP Global Conference on Clinical Pharmacy is designed for clinical practitioners, educators, residents, fellows, and pharmacy students engaged in all aspects of clinical pharmacy.

Program Goals

The educational program developed for the 2022 ACCP Global Conference will provide attendees with new, high-quality information that is both challenging and applicable to their practice. Program goals are to

  • Update clinical pharmacists on new therapeutic advances and management strategies;
  • Enhance attendees' clinical, research, teaching, and leadership skills;
  • Discuss the challenges of expanding the scope of pharmacy practice and emerging practice models; and
  • Present opportunities in clinical pharmacy and global health.
Claim CPE
Hide Speakers and Learning Objectives  
The Gut Microbiome as a Unique Metabolic Pathway for Drug Metabolism: Current Evidence and Future Directions
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-145-L01-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Douglas L. Jennings, Pharm.D., FCCP
    Associate Professor, Department of Pharmacy Practice
    Long Island University College of Pharmacy
    Brooklyn, New York
Learning Objectives
1. Analyze the interplay between the host, the human gut microbiome and drug metabolism.
2. Illustrate specific examples of how the microbiome interacts with drug metabolism, efficacy and toxicity.
3. Describe how the gut microbiome can play a role in precision medicine.
4. Evaluate the link between the gut microbiome and common psychiatric conditions.
5. Discuss the impact of the gut microbiome on the pharmacology of psychiatric medications.
6. Analyze the potential role of microbiome analysis on improving the care of patients with psychiatric conditions.
7. Discuss the relationship between the gut microbiome and cardiovascular disease.
8. Analyze the mechanistic link between the gut microbiome and vascular inflammation. 
9. Evaluate the influence of the gut microbiome on common cardiovascular medications.

The Gut Microbiome and Its Role in Drug Metabolism
  • Speaker: Kevin W. Garey, Pharm.D., FCCP, BCIDP
    Professor and Chair
    University of Houston College of Pharmacy
    Houston, Texas

The Role of the Gut Microbiome in Mental Health Conditions and Its Impact on Psychiatric Pharmacotherapy
  • Speaker: Stephanie A. Flowers, Pharm.D., Ph.D.
    Assistant Professor of Pharmacy Practice
    University of Illinois at Chicago
    Chicago, Illinois

The Gut Microbiome and Its Role in Cardiovascular Disease, Inflammation, Oxidative Stress, and Lipid Drug Therapy
  • Speaker: Sony Tuteja, Pharm.D.

    Research Assistant Professor 

    University of Pennsylvania Perelman School of Medicine

Global Antimicrobial Stewardship Forum: Current Controversies and Future Pathways
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-144-L01-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Khalid Eljaaly, Pharm.D., BCIDP, BCPS

    Associate Professor, Faculty of Pharmacy, and Head of Health Interprofessional Research Branch, King Abdulaziz University, Jeddah, Saudi Arabia

    Infectious Disease Pharmacy Consultant and Director of Infectious Disease Pharmacy Residency, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

    Honorary Research Fellow, College of Pharmacy, University of Arizona, Tucson, AZ, United States

    Chairman of Infectious Disease Pharmacy Practice Network of Saudi Society of Clinical Pharmacy

Learning Objectives
1. Describe antibiotic stewardship strategies for pharmacists in resource limited settings.
2. Analyze strategies to assist pharmacists in resource limited settings to develop an antimicrobial stewardship program.
3. Assess antimicrobial stewardship strategies that can impact global contribution to antibiotic resistance.
4. Identify difficult to treat pathogens that are recognized as global threats.
5. Construct antimicrobial regimens using novel agents to manage resistant bacterial infections.
6. Evaluate the role of timeworn antimicrobial agents in the treatment of resistant infections.
7. Incorporate rapid diagnostic testing in practice to shorten time to definitive therapy.
8. Apply current evidence to define the optimal antimicrobial treatment duration.
9. Select patients receiving intravenous antibiotics that are eligible for oral step-down therapy.

Antimicrobial Resistance: A Global Perspective
  • Speaker: Debra A. Goff, Pharm.D., FCCP

    Specialty Practice Pharmacist Infectious Diseases, The Ohio State University Wexner Medical Center;  Professor of Pharmacy Practice, OSU College of Pharmacy, Columbus, Ohio

Management of Difficult to Treat Bacterial Pathogens: A Focus on New Treatment Options
  • Speaker: Jason M. Pogue, Pharm.D., FCCP, BCIDP

    University of Michigan College of Pharmacy, Ann Arbor, MI

Evidence-Based Therapeutic Approaches to Optimize Antimicrobial Stewardship Initiatives
  • Speaker: P. Brandon Bookstaver, Pharm.D., FCCP, BCIDP

    Associate Professor & Director of Residency & Fellowship Training, University of South Carolina College of Pharmacy, Columbia, South Carolina

    Infectious Diseases Pharmacist and Director, PGY2 residency program, Prisma Health Richland, Columbia, South Carolina

    Director, PGY1 residency program, Tandem Health - University of South Carolina, Sumter, South Carolina

Moving Forward with Remote Experiential Education
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-146-L04-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Emily K. Flores, Pharm.D., BCPS
Learning Objectives
1. Discuss challenges encountered with the delivery of traditional IPPE and APPE rotations during the COVID-19 pandemic.
2. Construct simulation tools that may be utilized to teach patient care concepts when patients are not available.
3. Analyze the innovative structure of collaborative rotations spanning across many pharmacies, schools of pharmacy and rotation types.
4. Evaluate commonly used voice and video telehealth models/platforms used in health care settings.
5. Analyze facilitators and barriers to effectively incorporating learners into telehealth driven patient care (barriers to EMR access, etc).
6. Discuss strategies used to effectively incorporate learners in telehealth team-based patient care.
7. Describe approaches to remote experiential education that have been utilized around the world.
8. Delineate opportunities to utilize technology in expanding care to rural, underserved, and marginalized populations.
9. Discuss opportunities to catalyze global/international experiential rotations through technology without travel.

Novel Teaching Methods for When Patients are Not Available
  • Speaker: Mary Douglass Smith, Pharm.D.

    Director of Experiential Education, Presbyterian College School of Pharmacy

Integrating Telemedicine into APPE Education
  • Speaker: Korey Kennelty, Pharm.D., Ph.D., BCGP

    Department of Pharmacy Practice and Science
    College of Pharmacy
    &
    Department of Family Medicine
    Carver College of Medicine
    University of Iowa

Expanding to New Frontiers in APPEs with Technology
  • Speaker: Melody Ryan, Pharm.D., FCCP, BCGP, BCPS
    Professor
    University of Kentucky College of Pharmacy
    Lexington, Kentucky

Advances in Clinical Pharmacy Practice Around the World
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-148-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Jerry L. Bauman, Pharm.D., FCCP
    Dean Emeritus and Distinguished Professor Emeritus, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois
Learning Objectives
1. Recall a brief history of clinical pharmacy practice in the Middle East (UAE) and Asia.
2. Describe the training required to provide the clinical pharmacy services presented.
3. Identify innovative elements of the clinical pharmacy services presented.
4. Discuss credentialing requirements, including licensing and certifications.
5. Describe the impact on patient outcomes of the clinical services presented.

Clinical Pharmacy Practice at Cleveland Clinic in Abu Dhabi
  • Speaker: Bassam Atallah, Pharm.D., FCCP, BCPS

    Clinical Associate Professor
    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
    Senior Pharmacotherapy Specialist- Cardiology
    Cleveland Clinic Abu Dhabi, UAE

Monitoring Antifungal Therapy in Taiwan
  • Speaker: Shu-Wen "Wendy" Wendy Lin, Pharm.D.

    Associate Professor,
    Graduate Institute of Clinical Pharmacy, National Taiwan University
    Director,
    Department of Pharmacy, National Taiwan University Cancer Center

Digital Transformation of Clinical Pharmacy Services in Singapore
  • Speaker: Vivianne Shih, Pharm.D., BCOP, BCPS

    President, 116th Council 
    Pharmaceutical Society of Singapore 

    Specialist Pharmacist, National Cancer Centre Singapore 

The Role of Artificial Intelligence and Wearable Tech in the Profession of Pharmacy
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-147-L04-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Lawrence J. Cohen, Pharm.D., FCCP
    Professor of Pharmacotherapy; Coordinator of Interprofessional Education and Continuing Professional Education, University of North Texas, Fort Worth, Texas
Learning Objectives
1. Review the historical applications of artificial intelligence in health care.
2. Categorize key concepts of artificial intelligence embedded into clinical decision support tools (i.e. drug interaction programs) that pertain to pharmacy practice.
3. Analyze the role artificial intelligence has in optimizing current practice.
4. Define a step wise approach to implement artificial intelligence in practice.
5. Assess data output from artificial intelligence for clinical practice optimization.
6. Apply artificial intelligence applications in various pharmacy practice.
7. Describe the currently available wearable devices used in healthcare.
8. Appraise the current literature surrounding the use of wearable technology and how artificial intelligence is used to process data.
9. Apply the use of wearable technology to optimize patient outcomes and population health.

AI Part 1: Demystifying the Technologic Landscape: A Primer on AI for Clinicians
  • Speaker: Scott D. Nelson, Pharm.D.

    Program Director, MS-ACI
    Assistant Professor, Department of Biomedical Informatics
    Clinical Director, HealthIT

    Vanderbilt University Medical Center

AI Part 2: Help Artificial Intelligence Help You: Applications of AI in Pharmacy Practice
  • Speaker: Adrian Wong, Pharm.D., MPH, FCCP, FCCM, BCCCP

Health Fad Turned Medical Monitoring Device: Applications for Wearable Technology in Pharmacy Practice
  • Speaker: Michael P. Dorsch, Pharm.D., BCCP

    Associate Professor, University of Michigan College of Pharmacy

Successful Models of Medication Optimization Services for Medically Underserved and Socially Disadvantaged Populations
October 15, 2022 9:45 AM

Activity No. 0217-0000-22-192-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Omolola A. Adeoye-Olatunde, Pharm.D.
    Assistant Professor of Pharmacy Practice
    Purdue University, Center for Health Equity and Innovation
Learning Objectives
1. Discuss the intersection of social determinants of health and medication related health outcomes.
2. Identify challenges and enabling factors in achieving medication optimization in socially disadvantaged and medically underserved patients. 
3. Describe models of care which effectively incorporate and address Social Determinants of Health for medically underserved and socially disadvantaged patients.  
4. Analyze clinical results from models of care addressing social detriments of health in medically underserved and socially disadvantaged populations. 
5. Describe strategies for economic sustainability of medication optimization services within institutions serving medically underserved and socially disadvantaged patients. 

Incorporating Social Determinants of Health and Addressing Health Disparities through Medication Optimization Services: An Opportunity and Responsibility for Clinical Pharmacists
  • Speaker: Cheryl W. Wisseh, Pharm.D., MPH, BCACP

    Assistant Professor of Clinical Pharmacy, University of California at Irvine, School of Pharmacy & Pharmaceutical Sciences, Irvine, California; Assistant Professor, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles California; Primary Care Clinical Pharmacist, To Help Everyone Health and Wellness Center, Los Angeles, California 

Addressing Social Determinants of Health in Rural Communities
  • Speaker: Jon Easter

    Professor of the Practice, UNC Eshelman School of Pharmacy and Associate Faculty Director, Center for the Business of Healthcare, University of North Carolina, Chapel Hill, North Carolina

Advancing Equity through Comprehensive Service Delivery
  • Speaker: Sonak Pastakia, Pharm.D., Ph.D., MPH, FCCP

Questions and Answers Panel

ACCP Professional Leadership Development (APLD) Program: Building the Foundation for Leadership
October 15, 2022 1:00 PM

Activity No. 0217-0000-22-150-L04-P; 2.00 contact hours.
Knowledge Based Activity

  • Moderator: Miranda Andrus, Pharm.D., FCCP, BCPS

    Clinical Professor, Auburn University

  • Moderator: Leigh Ann Ross, Pharm.D., FCCP, BCPS

    Dean and Professor at Auburn University Harrison College of Pharmacy (AUHCOP)

  • Moderator: Elizabeth A. Farrington, Pharm.D., B.S.Pharm, FCCP, FCCM, FPPA, BCNSP, BCPPS, BCPS
    Pharmacist III - Pediatrics, Betty H. Cameron Women's and Children's Hospital, New Hanover Regional Medical Center, Wilmington, North Carolina
Learning Objectives
1. Describe one of your strength themes that was unexpected.
2. Define the four domains of team strength.
3. Based on your strengths, identify which of the four domains where you are most likely to contribute.
4. List at least 3 transformational decisions that have fostered the development or expansion of clinical pharmacy.
5. Describe the ACCP governance structure, as well as the types of governance used in other professional organizations.
6. Summarize a challenge faced by ACCP leadership and the approach taken to achieve resolution.

Leveraging Your Strengths as a Leader
  • Speaker: Marcia L. Buck, Pharm.D., FCCP, BCPPS
    Director, Clinical Practice Advancement, American College of Clinical Pharmacy, Washington, D.C.

Setting the Stage: A Brief History of Clinical Pharmacy and ACCP
  • Speaker: Michael S. Maddux, Pharm.D., FCCP

    Executive Director, American College of Clinical Pharmacy

  • Speaker: C. Edwin Webb, Pharm.D., MPH, FCCP
    Senior Policy Advisor, American College of Clinical Pharmacy, Washington, D.C.

Health Equity PRN Focus Session -- Health Equity: Moving From an Idea to Action
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-154-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Jacinda C. Abdul-Mutakabbir, Pharm.D., MPH, AAHIVP

    Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies

Learning Objectives
1. Describe the role of pharmacy and population health to achieve health equity.
2. Discuss how clinical pharmacists can positively impact population health.
3. Review the role of colleges of pharmacy and clinical training programs in reducing health disparities within their communities.
4. Recognize strategies to overcome barriers to the implementation and maintenance of a health equity center within a College of Pharmacy.
5. Express how pharmacy practitioners from different settings can reduce health disparities.
6. Recognize the methods to overcome challenges to achieving health equity that are applicable to a variety of clinical practice settings.

Examining the Intersectionality between Population Health and Health Equity: Applications in Pharmacy Clinical Training Programs
  • Speaker: Veronica Ajewole, Pharm.D., BCOP

    Associate Professor
    Department of Pharmacy Practice
    College of Pharmacy & Health Sciences
    Texas Southern University
    Houston, TX

    Oncology Clinical Pharmacist
    Houston Methodist Hospital
    Houston, TX

The Road Less Traveled: Establishing a Health Equity Research Institute Within a College of Pharmacy Pharmacy Program
  • Speaker: Omolola A. Adeoye-Olatunde, Pharm.D.
    Assistant Professor of Pharmacy Practice
    Purdue University, Center for Health Equity and Innovation

The Path to Health Equity: Perspectives from Education, Research, and Clinical Practice
  • Speaker: Alex R. Mills, Pharm.D., BCACP, AAHIVP

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN Focus Session -- Fast & Furious: The Future of Pharmacogenomics and Precision Medicine
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-152-L01-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Sony Tuteja, Pharm.D.

    Research Assistant Professor 

    University of Pennsylvania Perelman School of Medicine

Learning Objectives
1. Identify resources that may be utilized to guide implementation of drug-gene pairs without CPIC guidelines.
2. Discuss genes with implications for disease risk and medications.
3. Explain how genes influencing both disease risk and medications may be implemented in clinical systems.
4. Describe how artificial intelligence will be applied to identify patients at risk for a drug-gene interaction.
5. Discuss challenges in the implementation of novel genes.

The 2-year horizon: Approaches to gene-drug pairs that lack CPIC guidelines
  • Speaker: Kristine R. Crews, Pharm.D., BCPS
    Translational Research Laboratory Director, Pharmaceutical Sciences Department, St. Jude Children's Research Hospital, Memphis, Tennessee

The 5-year horizon: Addressing genes with implications for disease risk and medications
  • Speaker: Natasha Petry, Pharm.D., MPH

    Associate Professor of Practice - North Dakota State University

    Clinical Pharmacogenomics Pharmacist - Sanford Health Imagenetics

    Clinical Pharmacogenomics PGY-2 Residency Program Director - Sanford Health Imagenetics

The 10-year horizon: Integration of artificial intelligence with genomics to deliver precision medicine
  • Speaker: Arjun Prasanna Athreya, Ph.D.

    Senior Associate Consultant,

    Assistant Professor of Pharmacology,

    Dept. of Molecular Pharmacology and Experimental Therapeutics,

    Mayo Clinic, Rochester, MN.

Critical Care PRN Focus Session -- Back to the Future of Critical Care Pharmacotherapy
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-153-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Mojdeh S. Heavner, Pharm.D., FCCP, BCCCP
Learning Objectives
1. Identify innovative critical care pharmacy practice models and strategies for implementation.
2. Describe various extracorporeal modalities and their effect on the pharmacokinetics/pharmacodynamics of drug therapy.
3. Discuss the role and utility of therapeutic drug monitoring (TDM) in patients receiving extracorporeal therapies.
4. Describe integration of models of digital health technologies to optimize care provided in the ICU.
5. Discuss artificial intelligence (AI) applications and technologies available for use in the ICU and the role of the pharmacist in the research, development and implementation of AI tools.

Critical Care Pharmacy Practice Models of the Future
  • Speaker: Andrea Sikora, Pharm.D., FCCP, BCCCP

    Clinical Associate Professor, University of Georgia College of Pharmacy, Athens, Georgia

Great Scott! Is there a role for therapeutic drug monitoring in patients receiving extracorporeal therapies?
  • Speaker: Melissa Lynn Thompson Bastin, Pharm.D., Ph.D., FCCP, FCCM, BCCCP

    Critical Care Pharmacist, Medical Intensive Care Unit/Pulmonary
    Assistant Adjunct Professor, Department of Pharmacy Practice and Science
    University of Kentucky HealthCare
    University of Kentucky College of Pharmacy

The Future is Now: Digital Health and Artificial Intelligence in the ICU
  • Speaker: Todd N. Brothers, Pharm.D., BCCCP, BCPS

    Clinical Assistant Professor of Pharmacy Practice

    The University of Rhode Island

Examining Outcomes, Standards, and Professional Competencies
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-217-L04-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Pamela L. Stamm, Pharm.D., FCCP, BCACP, BCPS, CDE
Learning Objectives
1. Discuss different learning theories and constructs influence on teaching and learning at different levels.
2. Differentiate between traditional learning outcomes, ability-based outcomes, and competency-based education.
3. Review the different standards and professional competencies which guide pharmacy practice.
HIV PRN Focus Session -- Ending the HIV Epidemic: Best Practices for Personalizing HIV Prevention
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-151-L02-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Marisa Brizzi, Pharm.D., BCPS, AAHIVP

    Clinical Pharmacy Specialist - Pain Stewardship and HIV
    UC Health in Cincinnati, OH

Learning Objectives
1. Discuss how social determinates of health and racial/ethnic disparities lead to health inequity in HIV PrEP.
2. Evaluate strategies for improving the HIV PrEP care continuum across care settings.
3. Identify solutions to potential drug related problems with long-acting cabotegravir, including PK/PD challenges.
4. Describe how novel agents for HIV PrEP in the pipeline could help overcome current challenges.​
5. Outline opportunities for pharmacists to provide HIV PEP and PrEP services.
6. Illustrate potential strategies for pharmacist involvement in HIV screening and harm reduction initiatives.

Breaking the System: Acquiring Equitable Access to HIV Prevention Services and Medication
  • Speaker: Suzanne Molino, Pharm.D., BCACP

    Assistant Professor
    Division of Pharmacy Practice
    Long Island University
    Arnold & Marie Schwartz College of Pharmacy & Health Sciences
    Brooklyn, NY
    ​
    HIV Clinical Pharmacy Specialist
    Special Treatment and Research (STAR) Program
    One Brooklyn Health - Brookdale University Hospital Medical Center
    Brooklyn, NY  

PrEParing for the Future: New and Upcoming Formulations
  • Speaker: Emily Drwiega, Pharm.D., BCIDP, BCPS

    Visiting Clinical Assistant Professor of Pharmacy Practice, Clinical Pharmacist
    Section of Infectious Diseases Pharmacotherapy, Department of Pharmacy Practice
    University of Illinois at Chicago, College of Pharmacy

Best Practices for Pharmacist Driven HIV Prevention Services
  • Speaker: Betty J. Dong, Pharm.D.

    Professor, University of California San Francisco, School of Pharmacy and Medicine, San Francisco, California

Research Primer
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-221-L04-P; 4.00 contact hours.
Application Based Activity

  • Moderator: Michael E. Ernst, Pharm.D., FCCP, BCGP
    Clinical Professor, University of Iowa College of Pharmacy, Iowa City, Iowa
Learning Objectives
1. Describe the steps to formulating questions that are researchable.
2. Practice the interactive process of creating a defined and focused research question using PICO and FINER criteria.
3. Recognize basic concepts which underpin the research process and clinical investigation, such as the role of confounding variables and how different study designs account for their impact.
4. Describe key features of clinical research conducted using observational designs, survey research, educational research, and implementation science.

Welcome
  • Speaker: Michael E. Ernst, Pharm.D., FCCP, BCGP
    Clinical Professor, University of Iowa College of Pharmacy, Iowa City, Iowa

Introduction to Research Question and Clinical Investigation
  • Speaker: Michael E. Ernst, Pharm.D., FCCP, BCGP
    Clinical Professor, University of Iowa College of Pharmacy, Iowa City, Iowa

Breakout Sessions

Introductions to Study Designs
  • Speaker: Gary L. Cochran, Pharm.D.
    Associate Professor of Pharmacy Practice, University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska
  • Speaker: Margie E. Snyder, Pharm.D., MPH, FCCP

    Professor of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana

  • Speaker: Jeremy Thomas, Pharm.D.
    Associate Professor, Department of Pharmacy, University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock, Arkansas
  • Speaker: Jacqueline McLaughlin, Ph.D.
    Associate Professor, Educational Innovation and Research; Director of CIPhER, Center for Innovative Pharmacy Education and Research, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Leadership Primer, I
October 15, 2022 1:45 PM

Activity No. 0217-0000-22-225-L04-P; 4.00 contact hours.
Application Based Activity

  • Speaker: Peter D. Hurd, Ph.D.
    Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
  • Speaker: Robert E. Smith, Pharm.D.
    Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
Learning Objectives
1. Create meaning and reflection for your own leadership development path.
2. Discuss the importance of personal integrity and character in effective leadership.
3. Discuss the impact of too much or too little leadership and/or management on different types of organizations.
4. List the personal characteristics most people want in their leaders.
5. Describe the basics of organizational behavior.
6. Apply concepts and theories from organizational behavior literature to pharmacy settings.
7. Describe the various attributes of leadership.
8. Discuss the need for change in pharmacy practice environments.
9. Describe the various components of the Transtheoretical Model as it relates to leadership.
10. Apply the principles within the Transtheoretical Model to various practice settings.
11. Define leadership in terms used by various individuals.
12. Describe the various attributes of leadership.
13. Apply Blake and Mouton's work on motivation to various practice settings.
Establishing Outcomes
October 15, 2022 1:45 PM


  • Moderator: Daniel S. Longyhore, Pharm.D., FCCP, BCACP

    System Director for Knowledge Management, Geisinger, Enterprise Pharmacy

Examining Outcomes, Standards, and Professional Competencies
Activity No. 0217-0000-22-217-L04-P; 2.00 contact hours.

Aligning Goals and Objectives with Outcomes, Standards, and Professional Competencies
Activity No. 0217-0000-22-218-L04-P; 2.00 contact hours.

Clinical Pharmacy Education and Training: Global Perspectives
October 15, 2022 3:30 PM

Activity No. 0217-0000-22-149-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Alan H. Lau, Pharm.D.
    Professor and Director, International Clinical Pharmacy Education, University of Illinois Chicago College of Pharmacy, Chicago, Illinois
Learning Objectives
1. Recall a brief history of clinical pharmacy education and training in Europe, the UK, and Asia.
2. Describe the faculty and clinical resources required to deliver the levels of education and training presented.
3. Explain why the education/training program is unique or innovative within each region.
4. Discuss each program’s considerations of accreditation or certification.
5. Describe each program’s impact on student/trainee clinical competencies.

Status of Clinical Pharmacy Education in the EU and UK
  • Speaker: Lilian M. Azzopardi, Ph.D.

    Professor and Head of Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta; President, European Association of Faculties of Pharmacy

Clinical Pharmacy Education in the Philippines: Past, Present, and Future
  • Speaker: Aleth Therese L. Dacanay, Ph.D.

    DEAN
    Faculty of Pharmacy
    University of Santo Tomas
    Manila, Philippines

    PROGRAM LEAD
    Pharmacy & Medical Technology Cluster
    UST Graduate School

    CHAIRPERSON
    CHED Technical Panel for Pharmacy Education

    EXECUTIVE VICE PRESIDENT
    Philippine Pharmacists Association

Development of Residency Training Programs in Taiwan
  • Speaker: Hsiang-Yin Chen, Pharm.D.

    Professor and Associate Dean for Education, College of Pharmacy, Taipei Medical University

    President, ACCP Taiwan Chapter

Panel Discussion

Fostering a More Diverse Profession: Bringing Underrepresented Groups into the Pharmacy-Workforce Pipeline
October 15, 2022 3:30 PM

Activity No. 0217-0000-22-158-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Jimmi Hatton Kolpek, Pharm.D., FCCP

    Professor of Pharmacy, College of Pharmacy, Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky

  • Speaker: John M. Allen, Pharm.D., FCCP, BCPS

    Associate Dean for Diversity, Inclusion, and Health Equity & Clinical Associate Professor, University of Florida College of Pharmacy

  • Speaker: Hope E. Campbell, Pharm.D., BCPS

    Associate Professor, Pharmacy Practice, Belmont University College of Pharmacy, Nashville, Tennessee

  • Speaker: Marie Chisholm-Burns, Pharm.D., Ph.D., FCCP

    Executive Vice President and Provost

    J.S. Reinschmidt Endowed Professor

    Oregon Health & Science University

  • Speaker: Jimmi Hatton Kolpek, Pharm.D., FCCP

    Professor of Pharmacy, College of Pharmacy, Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky

Learning Objectives
1. Describe the disparities in race/ethnicity between the current pharmacy workforce and the United States population.
2. Explain the importance of a diverse school faculty in promoting greater diversity in the pharmacy workforce pipeline.
3. Identify at least 3 strategies to encourage students to consider pharmacy as a career.
4. Select recommendations from the panel that could be applied in promoting a more diverse pipeline during experiential education and residency.
5. Discuss strategies that could be integrated into ACCP activities to improve diversity in the pharmacy workforce pipeline.
Adult Medicine PRN and GI/Liver/Nutrition PRN Focus Session -- Are You a beLIeVER in Albumin and Proton Pump Inhibitors for Cirrhosis?
October 15, 2022 3:30 PM

Activity No. 0217-0000-22-155-L01-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Kelsey M. Rife, Pharm.D., BCACP
    Gastroenterology/Hepatology Clinical Pharmacist, VA Northeast Ohio Healthcare System;
    Clinical Program Manager – Academic Affairs, VA Northeast Ohio Healthcare System
    Cleveland, Ohio
Learning Objectives
1. Debate the use of long-term albumin infusion in cirrhosis and ascites.
2. Evaluate recent literature on the use of albumin in hospitalized patients with decompensated cirrhosis.
3. Debate the use of albumin for hyponatremia in hospitalized patients with cirrhosis.
4. Assess patients for complications of cirrhosis associated with the use of proton pump inhibitors.
5. Recommend an appropriate proton pump inhibitor regimen for use in a patient with cirrhosis.

The Pro Debate: Albumin for patients with ascites/decompensated cirrhosis and for hyponatremia in patients with cirrhosis
  • Speaker: Payal Kakadiya, Pharm.D., BCPS

    Internal Medicine/Digestive Health Clinical Pharmacist, Virginia Commonwealth University Health

The Con Debate: Albumin for patients with ascites/decompensated cirrhosis and for hyponatremia in patients with cirrhosis
  • Speaker: Kiya K. Bennett, Pharm.D., BCPS

    Internal Medicine Clinical Specialist, OU Health- University of Oklahoma Medical Center; Assistant Professor, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma

Safe Use of Proton Pump Inhibitors in Patients with Cirrhosis
  • Speaker: Brian L. Erstad, Pharm.D., FCCP, BCPS
    Professor and Head, Department of Pharmacy Practice & Science, College of Pharmacy, The University of Arizona, Tucson, Arizona

Hematology/Oncology PRN and Pharmaceutical Industries PRN Focus Session -- Translating Research into Practice: Contemporary Perspectives on the FDA Oncology Drug Approval Process and Novel Clinical Trial Designs
October 15, 2022 3:30 PM

Activity No. 0217-0000-22-157-L04-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Marco Martino, Pharm.D., MBA, BCOP, BCPS
    Operations Team Lead (Hematology/Oncology)
    Northwestern Medicine
    Chicago, Illinois
Learning Objectives
1. Describe the different FDA approval processes, including the accelerated approval pathway.
2. Assess the strengths and limitations in the accelerated approval process.
3. Evaluate surrogate endpoints used in the accelerated approval process.
4. Review novel clinical trial designs used in precision medicine, including basket and umbrella trials.
5. Compare and contrast limitations of novel trial designs used in oncology.
6. Interpret precision medicine trial data and how results can be integrated into practice.

The FDA Accelerated Approval Process: Too Fast or Just in Time?
  • Speaker: Val R. Adams, Pharm.D., BCOP
    Associate Professor
    University of Kentucky

Novel Precision Medicine Clinical Trial Designs in Oncology: A Primer for Pharmacists
  • Speaker: David L. DeRemer, Pharm.D., FCCP, BCOP
    Clinical Professor
    Assistant Director of Experimental Therapeutics
    University of Florida College of Pharmacy
    UF Health Cancer Center
    Gainesville, Florida

Cardiology PRN Focus Session -- Understanding the Alphabet Soup: Dissecting Device Therapies in Cardiovascular Disease
October 15, 2022 3:30 PM

Activity No. 0217-0000-22-156-L01-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Andrew J. Smith, Pharm.D., FCCP, BCCP, BCPS
Learning Objectives
1. Identify appropriate candidates LAAO devices, CardioMEMS, CRT, TAVR, or MitralClip.
2. Design an evidence-based pharmacotherapy strategy for patients after placement of LAAO device, Watchman device, CardioMEMs, CRT, TAVR, or MitralClip.
3. Formulate drug therapy plan for symptom management following TAVR, or MitraClip.

Analyzing the Role and Pharmacotherapy Implications of LAAO Devices and Watchman
  • Speaker: Kazuhiko Kido, Pharm.D., FCCP, BCCP, BCPS
    Clinical Associate Professor, West Virginia University School of Pharmacy
    Clinical Pharmacy Specialist, Advanced Heart Failure/Pulmonary Hypertension

Breaking Down CardioMEMS and CRT in Guideline-Directed Heart Failure Management
  • Speaker: Ian B. Hollis, Pharm.D., FCCP, BCPS
    Clinical Pharmacy Specialist, Cardiac Surgery & Advanced Heart Failure
    University of North Carolina Medical Center
    Chapel Hill, NC

Deconstructing Devices in Valvular Heart Disease: TAVR, MitralClip and their Effects on Antithrombotic Therapy and Symptom Management
  • Speaker: Arden Barry, Pharm.D.
    Clinical Pharmacy and Research Specialist and Associate Professor (Partner)
    Faculty of Pharmaceutical Sciences, University of British Columbia
    Vancouver, British Columbia, Canada

Aligning Goals and Objectives with Outcomes, Standards, and Professional Competencies
October 15, 2022 3:45 PM

Activity No. 0217-0000-22-218-L04-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Angela L. Bingham, Pharm.D., FCCP, BCPS

    Acting Chair and Clinical Associate Professor, Critical Care/Nutrition Support Clinical Pharmacy Specialist, PGY2 Critical Care Pharmacy Residency Program Director and Residency Programs Coordinator; Philadelphia College of Pharmacy, Saint Joseph's University; Philadelphia, PA

Learning Objectives
1. Compare and contrast knowledge, skills, and attitudes versus outcomes and competencies.
2. Discuss how to formulate goals and objectives to support outcome and competency development.
3. Create goals and objectives which align with outcomes, standards, and professional competencies.
New Investigator Award/Lecture — Merging Multiple National Data Sets to Evaluate Health Outcomes Associated with Pharmacologic Approaches to Glycemic Treatment
October 16, 2022 8:25 AM

Activity No. 0217-0000-22-215-L04-P; 0.25 contact hours.
Knowledge Based Activity

  • Award Winner: Erin R. Weeda, Pharm.D., BCPS
    Associate Professor, Medical University of South Carolina College of Pharmacy; Research Health Scientist, Ralph H. Johnson VA Medical Center, Charleston, South Carolina
Learning Objectives
1. Summarize guideline recommendations pertinent to sulfonylurea use.
2. Describe the association between sulfonylurea use and health outcomes.
Therapeutic Frontiers Lecture — Sepsis is a Metabolic Disease: Evidence from Metabolomics and Pharmacometabolomics
October 16, 2022 10:30 AM

Activity No. 0217-0000-22-216-L01-P; 0.50 contact hours.
Knowledge Based Activity

  • Award Winner: Kathleen A. Stringer, Pharm.D., FCCP
    Albert B. Prescott Collegiate Professor of Clinical and Translational Pharmacy, University of Michigan College of Pharmacy; Professor, Internal Medicine, Pulmonary and Critical Care Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan
Learning Objectives
1. Discuss sepsis and its impact on human health.
2. Review the science of metabolomics and pharmacometabolomics.
3. Describe how metabolomics can be used to phenotype sepsis and assess response to pharmacotherapy.
Leadership Primer, II
October 16, 2022 1:45 PM

Activity No. 0217-0000-21-096-L04-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Robert E. Smith, Pharm.D.
    Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
  • Speaker: Peter D. Hurd, Ph.D.
    Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
Learning Objectives
1. Describe the components of becoming a leader (Warren Bennis).
2. Apply concepts and theories from the leadership literature to pharmacy settings.
3. Describe the various attributes of leadership development.
4. Apply concepts and theories from organizational behavior literature to pharmacy settings.
5. Evaluate the use of principle-centered power in the pharmacy environment.
Equity in Healthcare Access: The Role of the Pharmacist
October 16, 2022 2:15 PM

Activity No. 0217-0000-22-163-L04-P; 4.00 contact hours.
Application Based Activity

  • Moderator: Nicole R. Alvey, Pharm.D., FAST, BCPS, BCTXP
Learning Objectives
1. Describe disparities related to culture, socio-economic status, gender, and geography.
2. Analyze how specific social determinants of health contribute to health disparities.
3. Identify the pharmacist’s role in achieving health equity, eliminating disparities, and improving the health of all people.
4. Identify factors contributing to poor health outcomes and increased mortality in patients living in rural communities.
5. Discuss the role of telemedicine in expanding healthcare resources to patients in rural communities.
6. Compare and contrast current pharmacy practice models being used to serve patients in rural communities.
7. Identify the role of the pharmacist in substance use prevention.
8. Summarize best practices involving pharmacists in the care of patients with known substance use disorders.
9. Demonstrate the development and execution of pharmacotherapeutic regimens for patients with active substance use disorders.
10. Identify barriers to providing optimal medical care in the transgender patient population.
11. Describe educational interventions needed to improve pharmacist knowledge to provide care to transgender patients.
12. Recognize ways in which pharmacists and pharmacies can raise awareness and become a trusted resource for the transgender patient population.
13. Identify patients at high risk for morbidity and mortality from chronic disease because of inadequate healthcare resources.
14. Analyze current barriers to underserved patient populations getting access to the appropriate medical care.
15. Compare and contrast current pharmacy practice models being used to serve patients at high risk of morbidity and mortality from chronic disease in underserved patient populations.
16. Describe the level of awareness of cultural competence and health equity instruction within pharmacy school curricula.
17. Design creative, evidence-based educational activities for pharmacy learners that promote cultural competence and health equity.
18. Identify opportunities for future research and collaboration amongst pharmacy schools in the United States to promote the standardized inclusion of cultural and equity-focused content within pharmacy curricula.

The Disparity Lifecycle: A Historical Perspective on Disparities in Healthcare, a Look at the Present Situation, and a Call to Action for the Future
  • Speaker: Kathleen B. Kennedy, Pharm.D.

    Dean, Xavier University of Louisiana College of Pharmacy

    Founding Director of the Center for Minority Health and Health Disparities Research and Education

Exploring Opportunities to Maximize Pharmacist Services in Rural Communities
  • Speaker: Shanna K. O'Connor, Pharm.D., BCACP

    Department Head & Associate Professor

    South Dakota State University College of Pharmacy

Pharmacist Contributions to Combating Substance Use Disorders
  • Speaker: Jeffrey P. Bratberg, Pharm.D.
    Clinical Professor, University of Rhode Island College of Pharmacy;
    Academic Collaborations Officer, Rhode Island Department of Health
    Kingston, Rhode Island

Advancing the Role of Pharmacists in Gender Affirming Care
  • Speaker: Kyle Melin, Pharm.D., BCPS

    Kyle Melin, Pharm.D., MSc, BCPS, AE-C
    Associate Professor
    School of Pharmacy
    Medical Sciences Campus -University of Puerto Rico

    Visiting Associate Professor & Fulbright Scholar
    University College Dublin School of Medicine

Improving Access to Primary Care Services for Underserved Populations: How A Pharmacist Can Help
  • Speaker: Sharon E. Connor, Pharm.D.
    Associate Professor, University of Pittsburgh, Pittsburgh, Pennsylvania

Laying Foundations: Guiding Principles for Teaching Diversity, Equity, and Inclusion in Pharmacy School Curricula
  • Speaker: Sally Arif, Pharm.D., BCCP

    Professor of Pharmacy Practice, Midwestern University College of Pharmacy-Downers Grove, IL

    Cardiology Clinical Pharmacist, Rush University Medical Center, Chicago, IL.

    Affiliated Faculty, Center for Community Health Equity, Chicago, IL.

Panel Discussion

International Clinical Pharmacy Research and Scholarship
October 16, 2022 2:15 PM

Activity No. 0217-0000-22-159-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Robert B. Parker, II, Pharm.D., FCCP
    Professor, University of Tennessee College of Pharmacy, Memphis, Tennessee
Learning Objectives
1. Recall a brief history of clinical pharmacy research and scholarship in the Middle East, Africa, and Asia.
2. Describe the research and scholarly experience required to pursue the work presented.
3. Explain why the focus of research/scholarship is unique or innovative within each region.
4. Discuss the various ways in which each work has been disseminated.
5. Describe each work’s potential impact on the field of clinical pharmacy.

Clinical Pharmacy Research in Saudi Arabia: Current Status and Future Directions
  • Speaker: Ahmed Hamdan Aljedai, Pharm.D., MBA, FCCP, BCPS

    Assistant Deputy Minister for Medical Support Services, Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia; Professor, Alfaisal University, College of Medicine, Consultant Clinical Pharmacist, Solid Organ Transplantation

Leveraging the Powers of Peers and Technology in Hypertension Care
  • Speaker: Benson Njuguna

    Senior Pharmacist, Moi Teaching and Referral Hospital

Prediction Models through Machine Learning Approaches to Facilitate Effective and Safe Medication Use in Taiwan
  • Speaker: Hsiang-Wen Lin, Ph.D.

    Professor,

    School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan 

Nephrology PRN Focus Session -- Improving Nephrology Clinical Outcomes with Existing Agents, New Medications, and Predictive Models
October 16, 2022 2:15 PM

Activity No. 0217-0000-22-160-L01-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Katherine Cho, Pharm.D., BCACP

    Clinical Assistant Professor – Ambulatory Care
    Temple University School of Pharmacy
    Philadelphia, Pennsylvania

Learning Objectives
1. Summarize recent scientific literature supporting use of pharmacologic agents to improve macro- and microvascular outcomes in patients with kidney disease.
2. Describe mechanism of action, initiation, adverse effects, and monitoring of novel nephroprotective drugs in patients with kidney disease.
3. Discuss strategies to facilitate multidisciplinary care, communication, and care transitions for patients with kidney disease on novel nephroprotective drugs.
4. Review current literature on predictive models of acute kidney injury (AKI).
5. Discuss disease-state specific literature demonstrating predictive models of acute kidney injury (AKI).
6. Summarize evidence supporting the use of cystatin C in assessing estimated glomerular filtration rate (eGFR) for medication dosing in comparison to standard renal estimates.

Cardio- and Nephroprotective Benefits of New Antidiabetic Agents
  • Speaker: Emily Ashjian, Pharm.D., BCACP, BCPS, CDCES

    Clinical Assistant Professor
    University of Michigan College of Pharmacy
    Ann Arbor, Michigan

The Newest Kid on the Nephrology Block: Finerenone
  • Speaker: Allissa Long, Pharm.D., BCACP

    Assistant Professor of Pharmacy Practice
    Massachusetts College of Pharmacy and Health Sciences - Boston
    Boston, Massachusetts

Updates on Predictive Models in Acute Kidney Injury and Cystatin C Use in Estimating Kidney Function
  • Speaker: Erin Frazee Barreto, Pharm.D., BCCCP, BCPS
    Associate Professor of Medicine and Pharmacy
    Mayo Clinic
    Rochester, Minnesota

Community-Based PRN Focus Session -- The Newest PRN on the Block: Where Do Community Pharmacists Fit in the Clinical Puzzle?
October 16, 2022 2:15 PM

Activity No. 0217-0000-22-162-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Emily Eddy, Pharm.D., BCACP
    Assistant Professor
    Director of Labs and Simulations
    Texas Tech Jerry H. Hodge School of Pharmacy
Learning Objectives
1. Recognize a product-centered versus patient-centered community pharmacist role.
2. Discuss patient care services commonly delivered by community pharmacists.
3. Describe key elements for successful implementation of community-based services and challenges or barriers that may be faced.
4. Describe commonalties, differences and collaboration opportunities between outpatient pharmacists practicing in different settings.
5. Discuss future opportunities for expansion of services in the community pharmacy setting.

Where Do I Begin?: Launching Community-Based Services as a New Practitioner
  • Speaker: Rebecca M. Lahrman, Pharm.D., BCACP

    Assistant Professor, The Ohio State University College of Pharmacy

Shifting Gears: Expanding and Sustaining Services in a Community Pharmacy
  • Speaker: Megan Smith, Pharm.D., BCACP

    Assistant Professor
    University of Arkansas for Medical Sciences

Looking Back: Lessons Learned in Building Community-Based Practices and Where They May be Headed
  • Speaker: Melissa S. McGivney, Pharm.D., FCCP
    Associate Dean, Community Partnerships
    Professor, Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, University of Pittsburgh
    Pittsburgh, Pennsylvania

Clinical Administration PRN Focus Session -- Fundamentals of the Pharmacy Workforce: Basics We Neglected During the Pandemic
October 16, 2022 2:15 PM

Activity No. 0217-0000-22-161-L04-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Nitish Bangalore, Pharm.D., BCPS

    Pharmacy Operations Manager, Children's Wisconsin, Milwaukee, WI

Learning Objectives
1. Describe how the coronavirus pandemic has presented challenges to the clinical pharmacy workforce.
2. Outline a formal process for preparing to recruit clinical pharmacists.
3. Describe the potential benefits of a formal onboarding process for clinical pharmacists.
4. Determine the essential components of a clinical pharmacist onboarding process.
5. Explain how succession planning can be used to build resiliency in pharmacy leadership.
6. Explore pathways that can be taken to identify leadership skills within clinical pharmacists and how to prepare such individuals for leadership roles.

How to Recruit Pharmacy Team Members: Where to Look, and When to Swipe Right
  • Speaker: Ashley F. Street, Pharm.D., MSHA

Welcome Aboard: Strategies for Orienting and Training New Team Members
  • Speaker: Joan A. Mege, Pharm.D., BCPS

    Director, Clinical Pharmacy Services, LifeBridge Health

Succession Planning: How to Find the Next Person Up
  • Speaker: Tyler A. Vest, Pharm.D., M.S., FNCAP, BCPS, BCSCP

Health Outcomes PRN Focus Session -- Implementation Science and Shared Decision Making – The Coolest New Kids on the Block
October 16, 2022 4:00 PM

Activity No. 0217-0000-22-164-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Aubrey Jones, Pharm.D.
Learning Objectives
1. Define implementation science and its major frameworks, and explain why it is important.
2. Discuss the pharmacist’s role in implementation science and identify areas at your site of practice where you could use implementation science to improve patient care.
3. Recognize the ethics and implications of shared decision making (SDM) on patient communication and care.
4. Recall and demonstrate main components of SDM.
5. Identify tools and resources to help implement SDM in your practice.

Implementing Implementation Science: Translating Research to Clinical Practice
  • Speaker: Laney K. Jones, Pharm.D., MPH

    Assistant Professor, Department of Genomic Health, Geisinger

Who, What, When, Why, and How – Shared Decision Making for Pharmacists
  • Speaker: Angela Fagerlin, Ph.D.

Questions and Answers Panel

Global Health PRN Focus Session -- Non-Communicable Disease Management at the Last-Mile: Where Global and Local Collide
October 16, 2022 4:00 PM

Activity No. 0217-0000-22-165-L04-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Lauren J. Jonkman, Pharm.D., MPH, BCACP

    Assistant Professor, University of Pittsburgh school of Pharmacy, Pittsburgh, Pennsylvania

Learning Objectives
1. Describe the differences in health outcomes and health inequities for non-communicable diseases between rural and urban communities across the globe.
2. Review explanatory frameworks for understanding drivers of health inequities in rural and remote locations.
3. Identify contextual and structural factors that influence health status among Indigenous peoples in North America and rural Kenya.
4. Describe pharmacist-supported interventions to improve non-communicable disease outcomes for indigenous populations.
5. Discuss community-based participatory research as a strategy to build capacity for non-communicable disease support.

Opportunities and challenges in achieving health equity in rural and remote areas
  • Speaker: Susie J. Crowe, Pharm.D.

    Director of Experiential Education, Assistant Professor, Department of Pharmacy Practice, Bill Gatton College of Pharmacy, Johnson City, Tennessee

Addressing chronic diseases among indigenous communities in remote areas of North America
  • Speaker: Sophia Yang, Pharm.D., BCPS

    Clinical Pharmacist, Northern Navajo Medical Center, Shiprock, NM (until 7/31/2022)

    Program Analyst, Asset Management Office, ICE Health Service Corps, Washington, DC (starting 8/1/2022)

Engaging communities for chronic disease management in rural Kenya
  • Speaker: Benson Njuguna

    Senior Pharmacist, Moi Teaching and Referral Hospital

Immunology/Transplantation PRN Focus Session -- Going Viral: Management of Complex Viral Infections and Immunosuppression Modulation in Solid Organ Transplantation
October 16, 2022 4:00 PM

Activity No. 0217-0000-22-167-L01-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Daniel C. Felix, Pharm.D., BCTXP
Learning Objectives
1. Describe the implications of respiratory viruses in transplantation.
2. Discuss influenza immunization approaches in solid organ transplantation population.
3. Outline the management of respiratory syncytial virus (RSV), parainfluenza virus (PIV), and influenza in transplant recipients.
4. Explain mechanisms of antiviral resistance and the role of various antiviral therapies in the treatment of ganciclovir-resistant CMV infections.
5. Identify strategies for immunosuppression augmentation in the setting of CMV infection.
6. Review literature surrounding therapies for prevention of BK-virus related complications.
7. Identify available therapy options for treatment of transplant recipients with symptomatic BK viruria or BK nephropathy.
8. Outline immunosuppression regimens for renal and non-renal transplant recipients with BK nephropathy.

Community Acquired Respiratory Viral Infections
  • Speaker: Angela T. Logan, Pharm.D., BCPS

    Lung Transplant Pharmacotherapy Specialist

    Tampa General Hospital, Tampa, FL

Management of Ganciclovir-Resistant Cytomegalovirus (CMV) Infections in Solid Organ Transplantation
  • Speaker: Cynthia Wong, Pharm.D.

    Clinical Transplant Pharmacist, Oregon Health & Science University

Management of BK Polyomavirus in Renal and Non-Renal Transplant Recipients
  • Speaker: Christina Teeter Doligalski, Pharm.D., BCPS
    Cardiothoracic Transplant Clinical Pharmacist, University of North Carolina at Chapel Hill Healthcare
    Assistant Professor of Clinical Education, UNC Eshelman School of Pharmacy
    Chapel Hill, North Carolina

BCACP Clinical Session: Don’t Go Viral with Antibiotics – How Pharmacists Can Use Antimicrobial Stewardship to Help Check Resistance at the Door
October 16, 2022 4:00 PM

Activity No. 0217-9999-22-069-L01-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Wiyanna K. K. Bruck, Pharm.D., BCIDP, BCPPS, BCPS
  • Speaker: Monica V. Mahoney, Pharm.D., FCCP, BCIDP, BCPS

    Clinical Pharmacy Specialist, Infectious Diseases; Beth Israel Deaconess Medical Center, Boston, Massachusetts

  • Speaker: Athena L.V. Hobbs, Pharm.D., BCIDP

    Infectious Diseases Clinical Manager Post Acute Medical, Cardinal Health Innovative Delivery Solutions

Learning Objectives
1. Interpret the Centers for Disease Control and Prevention core measures for antimicrobial stewardship in outpatient settings.
2. Evaluate the status of antimicrobial utilization and prescribing in outpatient facilities over the past several years.
3. Recommend antimicrobial stewardship interventions in outpatient settings using both traditional and novel approaches.
Infectious Diseases PRN and Society of Infectious Diseases Pharmacists Focus Session -- Extending the Reach of Antimicrobial Stewardship
October 16, 2022 4:30 PM

Activity No. 0217-0000-22-166-L01-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Andrea R. Chbeir, Pharm.D.
Learning Objectives
1. Identify ways that Antimicrobial Stewardship Program (ASP) extenders (non-infectious diseases clinicians) can support stewardship program activities and expansion
2. Describe different methods for teaching antimicrobial stewardship to non-infectious diseases clinicians and trainees in presented scenarios.
3. Describe the need for and advantages of a Tele-Outpatient Parenteral Antibiotic Therapy program
4. Explain social challenges faced with Tele-Outpatient Parenteral Antibiotic Therapy and a diverse population and recognize resources to overcome those challenges
5. Identify strategies to implement a Tele-Outpatient Parenteral Antibiotic Therapy program and metrics used to justify pharmacist involvement
6. List strategies for expanding Antibiotic Stewardship Program activities in various ambulatory care settings
7. List and explain interventions Emergency Department (ED) pharmacists can make to improve antimicrobial use in the ED

Best Practices for utilizing antimicrobial stewardship program extenders
  • Speaker: Elias B. Chahine, Pharm.D., FCCP, FASCP, FFSHP, BCIDP

    Professor of Pharmacy Practice, Palm Beach Atlantic University Gregory School of Pharmacy,
    Clinical Pharmacy Specialist, Wellington Regional Medical Center
    West Palm Beach, Florida

Extending Stewardship thru Tele-stewardship/OPAT initiative
  • Speaker: Rachel S. Britt, Pharm.D., BCIDP

    Pharmacy Clinical Practice Specialist - Infectious Diseases, University of Texas Medical Branch (UTMB) Health, Galveston, Texas

Antimicrobial Stewardship in the Emergency Department
  • Speaker: Yanina Dubrovskaya, Pharm.D., BCIDP, BCPS

    NYU Langone Health

BCOP Clinical Session: Taking a Deeper Dive: The Utilization of ctDNA and Minimal Residual Disease (MRD) to Assess Anticancer Therapeutic Response in Cancer
October 17, 2022 8:00 AM

Activity No. 0217-9999-22-070-L01-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Sandra Cuellar, Pharm.D., BCOP

    Clinical Associate Professor, University of Illinois Medical Center; Clinical Oncology Pharmacist, University Illinois at Chicago, Chicago, Illinois

  • Speaker: David L. DeRemer, Pharm.D., FCCP, BCOP
    Clinical Professor
    Assistant Director of Experimental Therapeutics
    University of Florida College of Pharmacy
    UF Health Cancer Center
    Gainesville, Florida
  • Speaker: Caitlyn L. Crawford, Pharm.D., BCOP

    Hematology/Oncology Clinical Pharmacy Specialist - Multiple Myeloma
    Atrium Wake Forest Baptist
    Winston-Salem North Carolina

Learning Objectives
1. Compare differences in the technologies utilized in solid tumor genomic profiling (tissue vs. plasma).
2. Assess the utility of measuring serial plasma cell-free (ctDNA) in therapy response assessment.
3. Describe minimal residual disease (MRD) testing methods.
4. Evaluate the impact and challenges of MRD in hematologic malignancies.
BCACP/BCGP Clinical Session -- Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults
October 17, 2022 8:30 AM

Activity No. 0217-9999-22-068-L01-P; 1.00 contact hour.
Application Based Activity

  • Speaker: Kimberly Zitko, Pharm.D., BCACP, BCGP

    Assistant Professor of Pharmacy Practice, South College School of Pharmacy

  • Speaker: Laura A. Schalliol, Pharm.D., BCACP, BCGP

    Associate Professor of Pharmacy Practice and PGY-1 Community-Based Residency Program Director

    South College School of Pharmacy, Knoxville, Tennessee

Learning Objectives
1. Assess common sleep disorders in an older adult patient population.
2. Apply evidence regarding the safety and efficacy of pharmacotherapy when used to treat common sleep disorders.
3. Identify and manage complicating factors encountered in the management of sleep complaints in older adult patients.
4. Design a treatment regimen addressing common sleep complaints in older adults.
5. Identify areas in which a clinical pharmacist can improve patient outcomes regarding sleep disorder management.
Beyond Provider Status: Developing, Advancing, and Positioning Clinical Pharmacists Through Interprofessional Efforts
October 17, 2022 8:30 AM

Activity No. 0217-0000-22-168-L04-P; 2.00 contact hours.
Application Based Activity

  • Moderator: Katherine D. Pham, Pharm.D., BCPPS
    Director, Policy and Professional Affairs, American College of Clinical Pharmacy (ACCP), Washington, D.C.
Learning Objectives
1. Examine interprofessional education efforts and illustrate their impact on preparing learners to work in team-based environments.
2. Explore collaborative strategies for advancing interprofessional education with physicians and other healthcare professionals.
3. Examine the perspectives of the physician community on pharmacists’ expertise and scope of practice and discuss opportunities for increasing clinical pharmacist visibility and involvement with physician organizations.
4. Explore strategies for interprofessional engagement and collaboration with physicians and other healthcare professionals to support practice advancement.
5. Describe the history of the pharmacy profession’s advocacy for provider status and distinguish ACCP’s position on provider status.
6. Explore strategies for interprofessional collaboration and advocacy with physicians and other healthcare professionals.
7. Formulate novel strategies to facilitate collaborative practice.

Interprofessional Education
  • Speaker: Kelly R. Ragucci, Pharm.D., FCCP, BCPS

    Vice President of Professional Development, American Association of Colleges of Pharmacy

    Professor Emeritus, Medical University of South Carolina

Interprofessional Collaboration
  • Speaker: Brian L. Erstad, Pharm.D., FCCP, BCPS
    Professor and Head, Department of Pharmacy Practice & Science, College of Pharmacy, The University of Arizona, Tucson, Arizona

Interprofessional Advocacy
  • Speaker: Curtis E. Haas, Pharm.D., FCCP
    Chief Pharmacy Officer
    University of Rochester Medical Center
    Rochester, New York

Panel Discussion

Storytelling as a Critical Strategy for Leaders
October 17, 2022 8:30 AM

Activity No. 0217-0000-22-224-L04-P; 2.00 contact hours.
Application Based Activity

  • Speaker: Todd D. Sorensen, Pharm.D., FCCP
    Professor and Senior Executive Associate Dean, University of Minnesota; Executive Director, Alliance for Integrated Medication Management, Minneapolis, Minnesota
Learning Objectives
1. Recognize evidence that supports the impact of public narrative in producing change in organizations.
2. Demonstrate how to develop a story using the challenge-choice-outcome model.
3. Using a personal situation, practice storytelling as an effective strategy for influence.
Clinical Reasoning Series in Pharmacotherapy – Part One: Updates in Management of Atrial Fibrillation
October 17, 2022 8:30 AM

Activity No. 0217-0000-22-228-L01-P; 3.00 contact hours.
Application Based Activity

  • Speaker: Audrey J. Jones, Pharm.D., MBA, BCCCP

    Pharmacy Manager, Perioperative Services and Controlled Substances​
    NewYork-Presbyterian Hospital
    New York, New York

  • Speaker: Keith Anderson, Pharm.D., BCCP
    Clinical Pharmacist
    Cleveland Clinic
    Cleveland, Ohio
  • Speaker: Stephanie Dwyer Kaluzna, Pharm.D.
    Clinical Assistant Professor / PGY2 Cardiology Residency Program Director, University of Illinois Chicago College of Pharmacy
    Cardiovascular Clinical Pharmacist, University of Illinois Hospital and Health Sciences System
    Chicago, Illinois
Learning Objectives
1. Describe the evolution of clinical evidence for rate versus rhythm control in the treatment of atrial fibrillation.
2. Identify patient characteristics that support early rhythm-control therapy for the treatment of atrial fibrillation.
3. Describe the evolution of the definition of valvular atrial fibrillation.
4. Develop an evidence-based anticoagulation treatment regimen for a patient with valvular atrial fibrillation.
Providing Care for Patients with Rare Disease
October 17, 2022 9:00 AM

Activity No. 0217-0000-22-169-L01-P; 1.50 contact hours.
Knowledge Based Activity

  • Moderator: Zach R. Smith, Pharm.D., FCCP, BCCCP, BCPS
    Clinical Pharmacy Specialist, Critical Care;
    PGY2 Critical Care Program Director
    Henry Ford Hospital
    Detroit, Michigan
Learning Objectives
1. Describe the criteria used to define a rare disease.
2. Summarize the unique elements in drug development for rare diseases.
3. Explain the challenges of patient recruitment to study rare diseases.
4. Describe the role of the pharmacist in the care of patients with rare diseases.
5. Summarize strategies to optimize drug therapy outcomes in rare diseases.
6. Identify solutions for obstacles encountered while caring for a patient with a rare disease.
7. Describe barriers to medication access in patients with a rare disease.
8. Develop a treatment approach to provide care for a patient with a rare disease throughout the care continuum.
9. Identify resources to facilitate patient access to high-cost specialty pharmacy medications.

Rare Diseases: What Every Pharmacist Needs to Know
  • Speaker: James C. Cloyd, Pharm.D., FCCP
    Professor and Director, Center for Orphan Drug Research College of Pharmacy, University of Minnesota Minneapolis, Minnesota

Clinical Pearls When Caring for a Patient with a Rare Disease
  • Speaker: Shubha Bhat, Pharm.D., FCCP, BCACP

    Clinical Pharmacy Specialist in Gastroenterology, Cleveland Clinic, Cleveland, Ohio

Managing Care Transitions and Medication Access for Patients with a Rare Disease
  • Speaker: Autumn D. Zuckerman, Pharm.D., BCPS, AAHIVP

    Director, Health Outcomes and Research

    Vanderbilt Specialty Pharmacy

Pandemics, Wildfires, and Natural Disasters
October 17, 2022 9:00 AM

Activity No. 0217-0000-22-170-L04-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Adriane N. Irwin, Pharm.D., MS, FCCP, BCACP

    Associate Professor (Clinical), Oregon State University (OSU) College of Pharmacy and Chair, Department of Pharmacy Practice

Learning Objectives
1. Correlate various types of public health emergencies and their effects on human health.
2. Articulate the core capabilities of national preparedness.
3. Contrast the roles of federal, state, and local agencies in emergency preparedness and response, including responsibilities in sustained response efforts.
4. Discuss how pharmacists can contribute to and support public health emergencies.
5. Describe how the drug supply and medication use process is altered during natural and manmade disasters.
6. Construct strategies for how pharmacists can volunteer to participate in emergency response efforts by federal agencies and similar agencies.
7. Describe strategies employed for addressing the immediate needs created by the COVID-19 pandemic.
8. Evaluate the impact of pharmacy practice changes in response to COVID-19 with a focus on long-lasting changes.
9. Identify strategies for preparedness for future pandemics and other natural or manmade disasters requiring emergency response.

Essentials of Emergency Preparedness
  • Speaker: Hoai-An Truong, Pharm.D., MPH

    Professor of Pharmacy Practice and Administration and Director of Public Health, University of Maryland Eastern Shore School of Pharmacy and Health Professions

Disaster Relief in Action: Reflections From the Frontline
  • Speaker: Erin M. Mullen, Ph.D.

    Regional Emergency Coordinator, Region 10

    HHS / Assistant Secretary for Preparedness and Response

The COVID-19 Response: What Worked, What Did Not, and How Has Practice Changed?
  • Speaker: Kyoung-Sil Kang, Pharm.D., BCOP, BCPS

    Director of Pharmacy

    BronxCare Health System

Update on Heart Failure Drug Therapies: 2022 Edition
October 17, 2022 9:00 AM

Activity No. 0217-0000-22-171-L01-P; 1.50 contact hours.
Application Based Activity

  • Moderator: Douglas L. Jennings, Pharm.D., FCCP
    Associate Professor, Department of Pharmacy Practice
    Long Island University College of Pharmacy
    Brooklyn, New York
Learning Objectives
1. Analyze the current evidence supporting novel drug therapies for heart failure across the spectrum of ejection fraction.
2. Describe strategies for how to transition HF patients to new evidence-based guideline-directed medications.
3. Construct comprehensive, evidence-based pharmacotherapy regimens for patients with heart failure across the spectrum of ejection fraction.
4. Evaluate process and data demonstrating how telehealth provides comprehensive heart failure medication management and improves medication adherence.
5. Discuss data and outcomes demonstrating how telehealth programs drive medication safety in the setting of polypharmacy.
6. Analyze social economic barriers and how to manage your patients’ costs and access to HF medications.
7. Discuss advances in durable device technology that have implications for drug therapy regimens.
8. Construct evidence-based drug therapy regimens for common complications such as gastrointestinal bleeding and thrombosis.
9. Evaluate opportunities for integrating novel heart failure drug therapies into the case of patients under durable LVAD support.

Heart Failure Drug Therapy in 2022: Moving Beyond ACE Inhibitors, Angiotensin Receptor Blockers and Beta-Blockers
  • Speaker: Orly Vardeny, Pharm.D., FCCP

    Core Investigator and Associate Professor of Medicine, Center for Care Delivery and Outcomes Research, Minneapolis VA Health Care System & University of Minnesota 

Telepharmacy Managing Medical Safety and Adherence in Heart Failure Patients
  • Speaker: Sheryl L. Chow
    Associate Professor, Western University of Health Sciences, Los Angeles, California

Contemporary Pharmacotherapy for Patients Under Durable LVAD Support
  • Speaker: Alana M. Ciolek, Pharm.D., MPH

    Clinical Pharmacy Manager Lead, NewYork-Presbyterian Hospital, New York, NY

BCACP/BCGP Clinical Session -- Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF
October 17, 2022 9:30 AM

Activity No. 0204-9999-22-331-L01-P; 1.50 contact hours.
Application Based Activity

    Learning Objectives
    1. Describe how historical heart failure therapies have failed to meet the needs of patients with HFpEF.
    2. Evaluate the evidence for mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors, and sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction.
    3. Analyze common scenarios where newer therapies may be able to provide clinical benefit to patients with HFpEF.
    4. Recommend a therapeutic plan for the management of a patient with heart failure with preserved ejection fraction using patient-specific factors.

    Welcome and Introduction

    Sooner or later, I'm greater than you: Review of HFpEF and Historic Management
    • Speaker: Tracy E. Macaulay Schwieterman, Pharm.D., FCCP, BCCP
      Clinical Pharmacist Specialist, Cardiology, Gill Heart Institute, University of Kentucky, Lexington, Kentucky

    Anything you can do...: Update on MRA and ARNI in HFmrEF and HFpEF
    • Speaker: Stormi Gale, Pharm.D., BCCP, BCPS

      Clinical Pharmacist, Cardiology Subject Matter Expert

    I can do better: Updates on SGLT2 inhibitors in HFmrEF and HFpEF
    • Speaker: Alina Kukin, Pharm.D., BCCP

      Cardiology Clinical Pharmacy Specialist, Hospital of the University of Pennsylvania, Philadelphia, PA

    I can do anything better then you... no you can't: Debate on management of HFpEF

    Yes I can!: Cases in HFpEF

    Wrap Up

    BCACP/BCGP Clinical Session -- Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer’s and Parkinson’s
    October 17, 2022 11:00 AM

    Activity No. 0204-9999-22-287-L01-P; 1.50 contact hours.
    Application Based Activity

      Learning Objectives
      1. Explain the mechanisms of anti-amyloid antibodies on the breakthrough therapy pathway.
      2. Evaluate anti-amyloid antibody treatment criteria, including strategies to mitigate and monitor for CNS adverse events in eligible patients.
      3. Assess implications of anti-amyloid immunotherapy approval and potential barriers to routine use.
      4. Develop an individualized treatment plan to optimize motor symptoms of PD utilizing novel therapies.
      5. Evaluate the use of medications for the treatment of non-motor symptoms of PD.

      Pharmacology and History
      • Speaker: Kristin Zimmerman, Pharm.D., BCGP
        Associate Professor, Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy, Richmond, Virginia

      Anti-amyloid Immunotherapy Data and Use

      Anti-amyloid Immunotherapy Therapy Controversy

      Updates in Parkinson’s Disease Motor Symptom Management
      • Speaker: Jenelle H. Montgomery, Pharm.D., BCACP

        Clinical Pharmacist Practitioner, Duke University Hospital; Assistant Professor of Clinical Education, UNC Eshelman School of Pharmacy

      Review of Parkinson’s Disease Psychosis and Orthostasis

      Questions, Answers, and Discussion

      Clinical Reasoning Series in Pharmacotherapy – Part Two: Considerations for Anticoagulation in Unique Populations and Scenarios
      October 17, 2022 1:00 PM

      Activity No. 0217-0000-22-229-L01-P; 3.00 contact hours.
      Application Based Activity

      • Speaker: Taylor Chuich, Pharm.D., BCPS
        Pharmacy Manager
        New York-Presbyterian Hospital, Columbia University Medical Center
        New York, New York
      • Speaker: Audrey J. Jones, Pharm.D., MBA, BCCCP

        Pharmacy Manager, Perioperative Services and Controlled Substances​
        NewYork-Presbyterian Hospital
        New York, New York

      • Speaker: Jackie P. Rowe, Pharm.D., BCPS

        Clinical Assistant Professor, ​Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey​

      Learning Objectives
      1. Describe the current practice guideline recommendations in regards to prophylaxis and treatment of left ventricular thrombus.
      2. Assess published literature in the off label use of direct oral anticoagulant therapy for left ventricular thrombus.
      3. Describe the evolution of anticoagulant use.
      4. Discuss safety considerations and risk mitigation strategies with anticoagulant agents.
      Emergency Medicine PRN Focus Session -- Toxicological Emergencies - Getting The NAC Of Envenomations – From Acetylcysteine to Snake Bites
      October 17, 2022 1:45 PM

      Activity No. 0217-0000-22-173-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Giles W. Slocum, Pharm.D., BCCCP, BCEMP
        Emergency Medicine Clinical Pharmacy Specialist, Rush University Medical Center;
        Assistant Professor, Rush Medical College
        Chicago, Illinois
      Learning Objectives
      1. Identify the optimal setting for alternative modes of administration of IV N-acetylcysteine in the treatment of acetaminophen toxicity.
      2. Debate the risks and benefits associated with Crotalinae (pit viper) equine immune F(ab')2 antivenom versus Ovine polyvalent crotalidae North and South American snake antivenom in the management of snake envenomation.
      3. Recommend solutions in overcoming barriers associated with stocking of high-cost antidotes and care transitions for disposition of patients with toxicological emergencies.

      NAC is Whack: It Doesn’t Have to Be 1-2-3
      • Speaker: Kristin Reinaker, Pharm.D.
        Clinical Assistant Professor, Ernest Mario School of Pharmacy at Rutgers University;
        Clinical Pharmacist - Emergency Medicine, Penn Medicine Princeton Medical Center

      Anavip: CroFab’s Two-Faced Friend Or Foe?
      • Speaker: Craig Cocchio, Pharm.D., BCPS

        Emergency Medicine Clinical Pharmacist
        CHRISTUS Mother Frances Hospital
        Tyler, Texas

      • Speaker: Faisal S. Minhaj, Pharm.D.
        Clinical Emergency Medicine Pharmacist/Toxicologist
        Wellstar Health System
        Kennestone Hospital
        Atlanta, GA

      Ambulatory Care PRN Focus Session -- Under Pressure: Approaches to Applying Blood Pressure Goals with Conflicting Guidelines and Evidence
      October 17, 2022 1:45 PM

      Activity No. 0217-0000-22-172-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Ann M. Philbrick, Pharm.D., FCCP, BCACP
        Associate Professor, University of Minnesota College of Pharmacy, Minneapolis, Minnesota; Bethesda Family Medicine Clinic, Saint Paul, Minnesota
      Learning Objectives
      1. Compare and contrast landmark hypertension trials.
      2. Apply hypertension trials and guidelines to patient specific scenarios.
      3. Evaluate patient specific factors that may correlate with more intense or less intense blood pressure goals.
      4. Compare and contrast national and international hypertension guidelines.

      What is the Best Blood Pressure Goal? Depends on Who you Ask.
      • Speaker: Andrew Hwang, Pharm.D., BCPS

        Associate Professor, MCPHS University School of Pharmacy, Boston, Massachusetts

      The Studies Say What? A Review of the Landmark Hypertension Studies Commonly Included in Hypertension Guidelines
      • Speaker: Lalita Prasad-Reddy, Pharm.D., MS, FCCP, BCACP, BCPS, CDE

      So What is the Best Option for My Patient? Application of Blood Pressure Guidelines Based on Patient Cases.
      • Speaker: Anthony Ishak, Pharm.D., BCPS

        Ambulatory Care Clinical Pharmacist, Beth Israel Deaconess Medical Center

      Q&A Panel with Session Speakers

      PSAP Live: Update to 2022 Book 1 (Cardiology)
      October 17, 2022 1:45 PM

      Activity No. 0217-0000-22-193-L01-P; 1.50 contact hours.
      Application Based Activity

      • Speaker: Craig J. Beavers, Pharm.D., FCCP, BCCP, BCPS
      • Speaker: Kelly M. Rudd, Pharm.D., FCCP, BCPS

        Clinical Associate Professor of Medicine - Oklahoma State University Center for Health Sciences College of Osteopathic Medicine, Tulsa, Oklahoma

        Clinical Pharmacy Specialist - Indian Health Service, Claremore, Oklahoma

      • Speaker: Stephanie Dwyer Kaluzna, Pharm.D.
        Clinical Assistant Professor / PGY2 Cardiology Residency Program Director, University of Illinois Chicago College of Pharmacy
        Cardiovascular Clinical Pharmacist, University of Illinois Hospital and Health Sciences System
        Chicago, Illinois
      Learning Objectives
      1. Develop a pharmacologic treatment plan for HFrEF and HFpEF that optimizes the use of traditional guideline-directed medical therapy.
      2. Distinguish the thrombotic pathophysiology of antiphospholipid syndrome (APS).
      3. Evaluate available evidence pertaining to the use of anticoagulants in patients with APS.
      4. Develop an appropriate guideline-driven pharmacotherapeutic treatment plan for a patient with APS.
      5. Design an antithrombotic treatment plan for a patient undergoing coronary stenting.
      6. Analyze recent literature surrounding modified regimens of dual antiplatelet therapy in patients with coronary artery disease and acute coronary syndromes.
      Research Basics
      October 17, 2022 1:45 PM

      Activity No. 0217-0000-22-222-L04-P; 4.00 contact hours.
      Knowledge Based Activity

      • Moderator: Michael E. Ernst, Pharm.D., FCCP, BCGP
        Clinical Professor, University of Iowa College of Pharmacy, Iowa City, Iowa
      Learning Objectives
      1. Describe common study designs used in observational, educational, health-services and cross-sectional/survey projects.
      2. Discuss the advantages and disadvantages of the various study designs.
      3. Discuss the optimal approach and suggested study design for your defined research question.
      4. Identify resources needed for your research question and ideas for securing support.

      Observational Research
      • Speaker: Gary L. Cochran, Pharm.D.
        Associate Professor of Pharmacy Practice, University of Nebraska Medical Center, College of Pharmacy, Omaha, Nebraska

      Survey Research
      • Speaker: Margie E. Snyder, Pharm.D., MPH, FCCP

        Professor of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana

      Implementation Science
      • Speaker: Jeremy Thomas, Pharm.D.
        Associate Professor, Department of Pharmacy, University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock, Arkansas

      Educational Research
      • Speaker: Jacqueline McLaughlin, Ph.D.
        Associate Professor, Educational Innovation and Research; Director of CIPhER, Center for Innovative Pharmacy Education and Research, University of North Carolina Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

      Personal Leadership Development
      October 17, 2022 1:45 PM

      Activity No. 0217-0000-22-226-L04-P; 4.00 contact hours.
      Application Based Activity

      • Speaker: Robert E. Smith, Pharm.D.
        Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
      • Speaker: Peter D. Hurd, Ph.D.
        Professor and Department Chair, Pharmaceutical and Administrative Sciences, St. Louis College of Pharmacy, St. Louis, Missouri
      Learning Objectives
      1. Create definitions for leadership and management.
      2. Discuss the importance of obedience to principles as a primary means for leading a successful life.
      3. Express how you can assume responsibility for achieving a full and balanced professional life.
      4. Construct a personal mission statement you can use as a guide to personal and professional achievement.
      5. Describe the importance of taking personal responsibility for self-leadership in developing leadership capabilities.
      6. Describe ways that you can be proactive when working with others in various settings, such as performance evaluation.
      7. Apply time management strategies, based on your mission statements, to your personal and professional leadership challenges.
      BCOP Clinical Session -- The Alphabet Soup of Hematologic Disorders: Background and Treatment Updates in ITP, TTP, HUS, and DIC
      October 17, 2022 2:00 PM

      Activity No. 0217-9999-22-071-L01-P; 2.00 contact hours.
      Application Based Activity

      • Speaker: Sarah Maryon Hayes, Pharm.D., BCOP

        Hematology/Oncology Clinical Pharmacy Specialist, North Memorial Health Care, Robbinsdale, Minnesota

      • Speaker: Kathryn Dane, Pharm.D.
        Clinical Pharmacy Specialist – Benign Hematology and Cardiology,
        Co-Director – Hemostatic and Antithrombotic Stewardship Program
        The Johns Hopkins Hospital
        Baltimore, Maryland
      • Speaker: Sebastian Cerdena, Pharm.D., BCOP

        Oncology Clinical Pharmacy Specialist

        Barnes Jewish Hospital

        St. Louis, MO

      Learning Objectives
      1. Illustrate understanding of the basic pathophysiology of immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and disseminated intravascular coagulation (DIC) and their associated drug therapies.
      2. Examine patients’ medication lists to identify common medications (including cancer treatments, immunotherapies, and drugs from other classes) implicated in the development of bleeding disorders.
      3. Compare and contrast pharmacologic standard-of-care and new therapies for the treatment of immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and disseminated intravascular coagulation (DIC).
      4. Show the relationship between COVID-19 (and COVID-19 vaccinations) and bleeding disorders, and how to approach the treatment of these disorders.
      5. Demonstrate the critical role of the clinical pharmacist in the procurement and administration of pharmacologic therapies used to treat bleeding disorders.
      Central Nervous System PRN Focus Session -- Exploring the High Seas of Treatment Considerations for Alzheimer’s Disease and Cognitive Impairment
      October 17, 2022 3:30 PM

      Activity No. 0217-0000-22-174-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Adam D. Gummersheimer, Pharm.D., BCPP, BCPS
      Learning Objectives
      1. Discuss the key features of Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) including course of illness and implications for patient care.
      2. Describe the current standards of care in the management of AD and MCI.
      3. Analyze the clinical data surrounding investigational, adjunctive, and novel therapies in the management of AD and MCI.
      4. Evaluate potential challenges and real-world considerations in the application of novel medication therapies in the care of patient’s living with AD or MCI.
      5. Apply evidence-based medicine describing novel medication therapies to optimize the care of patient’s living with AD or MCI.

      Let’s Set Sail - A clinical refresher on Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)
      • Speaker: Linda M. Sobeski, Pharm.D., BCPS
        Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska

      Going for a Dive - Review of the Data on Novel, Adjunctive, and Investigational Drug Therapies
      • Speaker: Crystal Burkhardt, Pharm.D., MBA, FCCP, BCGP
        Clinical Associate Professor, University of Kansas School of Pharmacy, Lawrence, Kansas

      Navigating the Perilous Seas – Challenges and Real World Considerations with the Use of These Novel and Investigational Therapies
      • Speaker: Viet-Huong V. Nguyen, Pharm.D., MPH, BCCCP

        Associate Professor (Neurology), Chapman University School of Pharmacy

      Pulmonary PRN Focus Session -- Calling Tech Support: Integrating Respiratory Technology into Clinical Practice
      October 17, 2022 3:30 PM

      Activity No. 0217-0000-22-176-L01-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Melissa Santibanez, Pharm.D., FCCM, BCCCP

        Assistant Professor, Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida; Critical Care Pharmacist Faculty, Memorial Regional Hospital, Hollywood, Florida

      Learning Objectives
      1. Identify the appropriate use for each presented device in patients with select respiratory conditions.
      2. Explain respiratory technology device data for therapeutic decision making.
      3. Review the financial return on the implementation of respiratory technology devices.
      4. Describe examples for pharmacist-driven services using respiratory technology devices.
      5. Given a respiratory device, identify if its use is for diagnosis, therapeutics, and/or monitoring.

      Respiratory Devices for Outpatient/Ambulatory Management: A Primer for Clinical Pharmacists
      • Speaker: Jeffrey Gonzales, Pharm.D., BCPS

        Clinical Pharmacy Specialist, Transitions of Care. St. Mary Medical Center, Langhorne PA.

      Respiratory Devices for Inpatient Management: A Primer for Clinical Pharmacists
      • Speaker: Brittany Verkerk, Pharm.D., BCCCP

        Senior Pharmacist, Adult Critical Care

        UC Davis Health

        Sacramento, CA

      Education and Training PRN Focus Session -- Paving the Road for Success - Early Intervention Strategies to Prevent Student Remediation
      October 17, 2022 3:30 PM

      Activity No. 0217-0000-22-175-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Ashley M. Higbea, Pharm.D., BCPS
      Learning Objectives
      1. Identify components of a culture of success.
      2. List methods for early identification of deficiencies in knowledge, skills and attitudes.
      3. Describe potential remediation and assessment strategies.
      4. Given an experiential case management referral, summarize strategies to support the academic and personal success of students.

      Paving the Road for Success- Early Intervention Strategies to Prevent Student Remediation: Starting at Home (Classroom)
      • Speaker: Julie J. Wilkinson, Pharm.D., BCPS

        Professor of Pharmacy Practice, LECOM School of Pharmacy, Bradenton, Florida

      Paving the Road for Success- Early Intervention Strategies to Prevent Student Remediation: Taking it on the Road (Experiential)
      • Speaker: Mary Douglass Smith, Pharm.D.

        Director of Experiential Education, Presbyterian College School of Pharmacy

      Paving the Road for Success- Early Intervention Strategies to Prevent Student Remediation: Creating a Road Map (Experiential Case Study Model)
      • Speaker: Jennifer R. Hamner, Pharm.D., FASHP

        Manager of Professional Development, Children's Hospital Colorado, Aurora, Colorado

      BCGP Clinical Session -- Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk
      October 17, 2022 4:00 PM

      Activity No. 0204-9999-22-302-L01-P; 1.00 contact hour.
      Application Based Activity

      • Speaker: Danielle Fixen, Pharm.D., BCGP
      Learning Objectives
      1. Using the CDC STEADI algorithm, develop a falls prevention process that incorporates pharmacists.
      2. Based on a review of the literature, assess medications with an increased fall risk in older adults.
      3. Recommend medication strategies to decrease falls in older adults.
      Clinical Reasoning Series in Critical Care Pharmacy – Part One: Endocrine Resuscitation in Septic Shock
      October 18, 2022 8:30 AM

      Activity No. 0217-0000-22-230-L01-P; 3.00 contact hours.
      Application Based Activity

      • Speaker: Mahmoud Ammar, Pharm.D., BCCCP, BCPS
        Critical Care Clinical Pharmacy Specialist - Trauma-Surgical, Yale New Haven Health
        Clinical Associate Professor, University of Connecticut School of Pharmacy
        New Haven, Connecticut
      • Speaker: Melissa Lynn Thompson Bastin, Pharm.D., Ph.D., FCCP, FCCM, BCCCP

        Critical Care Pharmacist, Medical Intensive Care Unit/Pulmonary
        Assistant Adjunct Professor, Department of Pharmacy Practice and Science
        University of Kentucky HealthCare
        University of Kentucky College of Pharmacy

      • Speaker: Brittany D. Bissell, Pharm.D., Ph.D., BCCCP
        Assistant Professor, University of Kentucky College of Medicine;
        Assistant Professor, University of Kentucky College of Pharmacy
        Lexington, Kentucky
      Learning Objectives
      1. Recognize the role of the endocrine system and endocrinopathy in the pathogenesis of sepsis.
      2. Appraise the evidence surrounding the impact of thyroidal hormone supplementation as a therapeutic intervention in the critically ill population.
      3. Examine the role of non-catecholamine vasopressors in the pathogenesis of septic shock.
      4. Formulate a septic shock treatment plan using non-catecholamine vasopressors as a therapeutic intervention.
      Incorporating Diversity, Equity, and Inclusion Principles in Pharmacy Experiential Education
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-181-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Marcia L. Buck, Pharm.D., FCCP, BCPPS
        Director, Clinical Practice Advancement, American College of Clinical Pharmacy, Washington, D.C.
      Learning Objectives
      1. Describe the negative impact that unconscious bias and microaggressions have on learners and the profession.
      2. Identify strategies that preceptors / mentors can use to create a supportive and psychologically safe environment for students and residents.
      3. Provide feedback in a manner that acknowledges strengths and promotes growth.
      4.  Define health equity and describe its intersectionality with experiential education.
      5. Summarize components of the five key domains of social determinants of health (SDOH).
      6. Identify key considerations for intentionally incorporating health equity education for experiential learners.

      Establishing Supportive Mentoring Relationships with Students and Residents
      • Speaker: Stuart T. Haines, Pharm.D., FCCP, BCACP, BCPS

      Getting Uncomfortable: Integrating Health Equity into Experiential Education
      • Speaker: Sharmon P. Osae, Pharm.D., BCACP, CDCES

        Clinical Assistant Professor

        University of Georgia College of Pharmacy

      SoMe What You Can Do! Using Social Media for Clinical Education, Professional Development, and Residency Recruitment Expansion
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-177-L04-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Erika L. Hellenbart, Pharm.D., BCPS
      Learning Objectives
      1. Describe student and trainee perceptions of social media in education.
      2. Illustrate best practices for using social media in experiential education.
      3. Employ strategies to incorporate social media into didactic and experiential education.
      4. Discuss the growing impact of social media on pharmacist development.
      5. Examine how various social media platforms may be utilized for pharmacy professional development, collaboration, and scholarship.
      6. Explore the role of institutional social media accounts for engaging employees in professional development and networking.
      7. Summarize the necessity of using social media to expand the scope of your residency recruitment efforts.
      8. Compare and contrast the various social media platforms in regards to advantages and disadvantages for use in residency recruitment.
      9. Outline best practices for promoting your residency on social media.

      See What's Trending: Utilizing Social Media in Didactic and Experiential Pharmacy Education
      • Speaker: Brooke L. Griffin, Pharm.D., BCACP
        Associate Professor, Midwestern University, Downers Grove, Illinois

      What is Your Strategy? Best Practices for Utilizing Social Media for Professional Development
      • Speaker: Arden Barry, Pharm.D.
        Clinical Pharmacy and Research Specialist and Associate Professor (Partner)
        Faculty of Pharmaceutical Sciences, University of British Columbia
        Vancouver, British Columbia, Canada

      Branching Out: Using Social Media to Optimize and Expand Residency Recruitment Efforts
      • Speaker: Kamakshi V. Rao, Pharm.D., BCOP

        Assistant Director of Pharmacy

        UNC Medical Center

        Professor of Clinical Education

        UNC Eshelman School of Pharmacy

      Down to the Wire: Late Breaking Clinical Trials
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-178-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Megan A. Rech, Pharm.D., FCCP, BCPS
        Emergency Medicine Clinical Pharmacist, Department of Pharmacy, Loyola University Medical Center;
        Research Coordinator, Department of Emergency Medicine, Loyola University Chicago
        Maywood, Illinois
      Learning Objectives
      1. Evaluate late-breaking pharmacotherapy medical literature that impacts patient care and/or health care outcomes.
      2. Describe limitations and controversies associated with these late-breaking data.
      3. Discuss the implications of late-breaking data on current clinical practice.

      Infectious Disease
      • Speaker: Jacinda C. Abdul-Mutakabbir, Pharm.D., MPH, AAHIVP

        Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies

      Cardiology
      • Speaker: Bassam Atallah, Pharm.D., FCCP, BCPS

        Clinical Associate Professor
        Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
        Senior Pharmacotherapy Specialist- Cardiology
        Cleveland Clinic Abu Dhabi, UAE

      Oncology
      • Speaker: Amanda N. Seddon, Pharm.D., BCOP, BCPS

        Associate Professor, Midwestern University College of Pharmacy, Downers Grove Campus

      Critical Care
      • Speaker: Melissa Lynn Thompson Bastin, Pharm.D., Ph.D., FCCP, FCCM, BCCCP

        Critical Care Pharmacist, Medical Intensive Care Unit/Pulmonary
        Assistant Adjunct Professor, Department of Pharmacy Practice and Science
        University of Kentucky HealthCare
        University of Kentucky College of Pharmacy

      Solid Organ Transplantation
      • Speaker: Christina Teeter Doligalski, Pharm.D., BCPS
        Cardiothoracic Transplant Clinical Pharmacist, University of North Carolina at Chapel Hill Healthcare
        Assistant Professor of Clinical Education, UNC Eshelman School of Pharmacy
        Chapel Hill, North Carolina

      Pediatrics
      • Speaker: Titilola M. Afolabi, Pharm.D., FCCP, BCPPS

        Associate Professor, College of Pharmacy, University of Tennessee Health Science Center

      Global Community Clinical Pharmacy Practice
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-179-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Brian A. Hemstreet, Pharm.D., FCCP, BCPS

        Associate Dean for Student Affairs and Professor. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Aurora, Colorado 

      Learning Objectives
      1. Recall a brief history of community clinical pharmacy practice in Europe.
      2. Describe the resources required to deliver clinical pharmacy services in the community pharmacy setting in each country/region.
      3. Explain why the clinical services described are unique or innovative within each country/region.
      4. Discuss how each program addresses quality improvement.
      5. Describe each service’s impact on patient outcomes.

      Post-COVID Community Pharmacy Practice in Portugal
      • Speaker: Ema Paulino, Pharm.D.

        President, Portuguese National Pharmacy Association (ANF)

      How Will the Post-COVID-19 Era Look for Community Pharmacy in Malta
      • Speaker: Catherine Anne A. Busuttil, Pharm.D.

        Doctor of Pharmacy, University of Malta

      Community Clinical Practice in Ireland
      • Speaker: Amar Abbas, Pharm.D., MPH

        Advanced Scientific Initiatives Senior Pharmacist 

        Medicines Authority - Malta

      Panel Discussion

      PSAP Live: Update to 2022 Book 1 (Cardiology) (encore)
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-193-L01-P; 1.50 contact hours.
      Application Based Activity

      • Speaker: Craig J. Beavers, Pharm.D., FCCP, BCCP, BCPS
      • Speaker: Kelly M. Rudd, Pharm.D., FCCP, BCPS

        Clinical Associate Professor of Medicine - Oklahoma State University Center for Health Sciences College of Osteopathic Medicine, Tulsa, Oklahoma

        Clinical Pharmacy Specialist - Indian Health Service, Claremore, Oklahoma

      • Speaker: Stephanie Dwyer Kaluzna, Pharm.D.
        Clinical Assistant Professor / PGY2 Cardiology Residency Program Director, University of Illinois Chicago College of Pharmacy
        Cardiovascular Clinical Pharmacist, University of Illinois Hospital and Health Sciences System
        Chicago, Illinois
      Learning Objectives
      1. Develop a pharmacologic treatment plan for HFrEF and HFpEF that optimizes the use of traditional guideline-directed medical therapy.
      2. Distinguish the thrombotic pathophysiology of antiphospholipid syndrome (APS).
      3. Evaluate available evidence pertaining to the use of anticoagulants in patients with APS.
      4. Develop an appropriate guideline-driven pharmacotherapeutic treatment plan for a patient with APS.
      5. Design an antithrombotic treatment plan for a patient undergoing coronary stenting.
      6. Analyze recent literature surrounding modified regimens of dual antiplatelet therapy in patients with coronary artery disease and acute coronary syndromes.
      7. Distinguish between the various antithrombotic treatment regimens indicated for patients undergoing transcatheter aortic valve implantation.
      Advancing Medication Optimization through State-Based Models and Legislative Efforts
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-182-L03-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: John K. McGlew
        Director, Government Affairs, American College of Clinical Pharmacy (ACCP), Washington, D.C.
      Learning Objectives
      1. Outline the policy principles of ACCP’s advocacy platform to establish formal, statutory coverage for comprehensive medication management (CMM) services as it relates to the Social Security Act.
      2. Discuss the importance of state-based advocacy and the potential implications of upcoming 2022 midterm elections.
      3. Explain the legislative advancements of SB 21-094 and HB21-1275 in Colorado and their potential impact on the advancement of clinical pharmacy practice.
      4. Identify future opportunities and barriers in the implementation of SB21-094 and HB21-1275.
      5. Summarize the key components of the Maryland Primary Care Program and the implementation of comprehensive medication management in a diversity of practice models.
      6. Discuss the opportunities for clinical pharmacists and collaborative practice in CMMI models and other value-based payment initiatives.

      The State and Federal Legislative Landscape
      • Speaker: Paul T. Kelly
        President, Capitol Advocacy and Government Affairs, LLC, Washington, D.C.

      State-Based Legislative Efforts in Colorado
      • Speaker: Emily Zadvorny, Pharm.D., BCPS

        Executive Director, Colorado Pharmacists Society

      State-Based Payment Models: Maryland Primary Care Program
      • Speaker: Magaly Rodriguez De Bittner, Pharm.D.

        CIPS Executive Director, University of Maryland, Baltimore, Maryland

      Panel Discussion

      Getting Things Done in Organizations
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-21-238-L04-P; 2.00 contact hours.
      Application Based Activity

      • Speaker: Robert E. Smith, Pharm.D.
        Professor Emeritus, Harrison School of Pharmacy, Auburn University, Auburn, Alabama
      Learning Objectives
      1. Review personal development principles.
      2. Discuss the elements of successful teams.
      3. Relate the importance of controlling ego.
      4. Apply the learned concepts to roles within ACCP and back home.
      5. Conduct a warm-up team building exercise.
      Discovering Pieces to the Puzzle: What a Non-Psych Pharmacist Needs to Know About Mental Health Medications
      October 18, 2022 10:15 AM

      Activity No. 0217-0000-22-180-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Krystal KC Riccio, Pharm.D., BCACP
        Associate professor of Pharmacy Practice, Roseman University of Health Sciences College of Pharmacy;
        Clinical Pharmacist, Center for Behavioral Health
        Las Vegas, Nevada
      Learning Objectives
      1. Evaluate current recommendations, including newer approved medications, for the treatment of mood disorders.
      2. Construct monitoring plans for the medications utilized in the treatment of mood disorders.
      3. Describe screening tools to improve diagnostic precision (e.g., major depressive disorder versus bipolar disorder).
      4. Evaluate current recommendations, including newer approved medications and formulations, for the treatment of schizophrenia.
      5. Discuss the risks and benefits of using long-acting injectable formulations in the treatment of schizophrenia.
      6. Construct drug therapy monitoring plans for the medications utilized in the treatment of schizophrenia.
      7. Evaluate current recommendations and therapeutics for the treatment of each anxiety disorder.
      8. Discuss the necessity for acute versus chronic treatment of various anxiety disorders.
      9. Construct effective monitoring plans for the medications utilized in the treatment of anxiety disorders.

      Fitting the Pieces Together When Designing Drug Therapy Regimens for Mood Disorders
      • Speaker: Richard J. Silvia, Pharm.D., FCCP, BCPP

      Identifying Pieces that Fit for Schizophrenia: A Medication Therapy Primer
      • Speaker: Melissa C. Palmer, Pharm.D., BCPP, BCPS
        Clinical Pharmacy Specialist – Mental Health, Alaska VA Healthcare System, Anchorage, Alaska

      One Size Does Not Fit All in the Treatment of Anxiety
      • Speaker: Benjamin Chavez, Pharm.D., BCACP

        Director of Behavioral Health Pharmacy Services/ Clinical Pharmacist
        Salud Family Health 

      Clinical Reasoning Series in Critical Care Pharmacy – Part Two: Alternative Therapeutics for Septic Shock
      October 18, 2022 1:00 PM

      Activity No. 0217-0000-22-231-L01-P; 3.00 contact hours.
      Application Based Activity

      • Speaker: Melissa Lynn Thompson Bastin, Pharm.D., Ph.D., FCCP, FCCM, BCCCP

        Critical Care Pharmacist, Medical Intensive Care Unit/Pulmonary
        Assistant Adjunct Professor, Department of Pharmacy Practice and Science
        University of Kentucky HealthCare
        University of Kentucky College of Pharmacy

      • Speaker: Brooke Barlow, Pharm.D., BCCCP

        Neurocritical Care Clinical Pharmacy Specialist

        Memorial Hermann The Woodlands Medical Center

        The Woodlands, Texas

      • Speaker: Carolyn Magee Bell, Pharm.D., BCCCP
        Medical−Surgical ICU Clinical Pharmacy Specialist
        Medical University of South Carolina (MUSC)
        Charleston, South Carolina
      Learning Objectives
      1. Describe the pathophysiology of sepsis and septic shock highlighting the role of coagulation, immune, and neurohormonal system.
      2. Discuss the potential role of antithrombotics, statins, beta blockers, alpha adrenergic antagonists, and immune modulation in the management of sepsis and septic shock.
      3. Analyze the current literature evaluating alternative therapies in sepsis and septic shock.
      4. Given a patient case, implement alternative therapies for sepsis and septic shock into clinical practice.
      Women's Health PRN Focus Session -- Where Do We Go From Here? Lessons Learned Providing Reproductive Health Care during the COVID-19 Pandemic
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-188-L04-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Lauren Leader, Pharm.D., BCPS
        Clinical Pharmacy Specialist - Obstetrics and Gynecology, Michigan Medicine, Ann Arbor, Michigan
      Learning Objectives
      1. Discuss barriers to COVID-19 treatment and prevention in pregnant and breastfeeding patients.
      2. Review misinformation and emerging evidence about COVID-19 infection and vaccination effects on reproductive health.
      3. Formulate strategies to overcome barriers related to COVID-19 treatment and prevention in males and females of reproductive age.

      COVID-19 in Pregnant and Breastfeeding Patients
      • Speaker: Christina M. Madison, Pharm.D., FCCP, AAHIVP
        Associate Professor of Pharmacy Practice, Roseman University of Health Sciences Founder and CEO, The Public Health Pharmacist, PLLC Las Vegas, Nevada

      The Effects of COVID-19 on Infertility
      • Speaker: Alexis Ireland, Pharm.D.

        Clinical Pharmacy Specialist, University of Iowa Center for Advanced Reproductive Care, Iowa City, IA

      Defining Success in Teaching, Learning, and Development
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-219-L04-P; 2.00 contact hours.
      Application Based Activity

      • Speaker: Kylie N. Barnes, Pharm.D., FCCP, BCPS

        Director of Applied Skills and OSCE Implementation University of Missouri Kansas City School of Pharmacy

      Learning Objectives
      1. Identify the link between criteria and objectives with learner and professional evaluations.
      2. Discuss traditional and non-traditional methods for determining learner and professional development, progress, and success.
      3. Explore different processes for assuring the reliability and usefulness of criteria in evaluation.
      Pediatrics PRN Focus Session -- An Intersection of Global Crises: Pediatric Psychiatry in the Time of COVID-19
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-184-L01-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Brent A. Hall, Pharm.D., BCPPS
      Learning Objectives
      1. Identify pediatric psychiatric disorders which have and are increasing in frequency during the COVID-19 pandemic.
      2. Review appropriate therapies and monitoring for psychiatric disease states including Anxiety, Depression and Adjustment Disorder.
      3. Outline a treatment plan for a pediatric patient with pandemic-associated anxiety.
      4. Summarize how pharmacogenomics can be utilized to maximize efficacy of pediatric psychiatric medications.
      5. Discuss common toxidromes associated with overdose of psychiatric medications.
      6. Identify appropriate management strategies for psychiatric medication overdoses.

      Emerging Pediatric Psychiatric Disorders during the COVID -19 pandemic
      • Speaker: Kimberly B. Tallian, Pharm.D., F
        Advanced Practice Pharmacist - Psychiatry, Scripps Mercy Hospital, San Diego

      Pharmacogenomic optimization of pediatric psychiatric medications
      • Speaker: David Gregornik, Pharm.D.

        Director, Pharmacogenomics Program, Children's Minnesota

      Assessing and treating psychiatric medication overdoses
      • Speaker: Kimberly Jones, Pharm.D., BCPPS, BCPS

        Patient Care Pharmacist in Emergency Medicine, Nationwide Children's Hospital, Columbus, OH

      Endocrine and Metabolism PRN and Nephrology PRN Focus Session -- Chronic Kidney Disease and SGLT2 Inhibitors
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-187-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Sara W. Reece, Pharm.D., FCCP, BCACP
        Associate Professor and Vice Chair, Pharmacy Practice, and Director of IPE, Philadelphia College of Osteopathic Medicine Georgia Campus School of Pharmacy;
        Ambulatory Care Pharmacist and Core Faculty, Northeast Georgia Medical Center Family Medicine GME Program
        Gainesville, Georgia
      Learning Objectives
      1. Summarize the updated guidelines for diabetes related chronic kidney disease and role of SGLT-2 inhibitors in CKD.
      2. Demonstrate the evidence that supports the use of SGLT-2 inhibitors in persons with diabetes related kidney disease when eGFR is less than or equal to 30 ml/min/1.73sq.m.
      3. Apply the evidence that limits use of SGLT-2 inhibitors in persons with diabetes related kidney disease when eGFR is less than or equal to 30 ml/min/1.73sq.m.

      Update on Treatment of Diabetes Related CKD and the Role of SGLT-2 Inhibitors
      • Speaker: Katie E. Cardone, Pharm.D., FCCP, BCACP

        Associate Professor and PharmD program director, Albany College of Pharmacy and Health Sciences, Albany, New York

      Pro Debate: Building a Case for SGLT-2 Inhibitors in Diabetes Related CKD
      • Speaker: Christine A. Schumacher, Pharm.D., FCCP, BCACP, BCCP, BCPS

        Professor, Pharmacy Practice
        Director, PGY2 Ambulatory Care Residency Program
        Midwestern University College of Pharmacy, Downers Grove Campus (CPDG)
        Clinical Pharmacist, Advocate Medical Group

      Con Debate: Limiting the Use of SGLT-2 Inhibitors in Diabetes Related CKD
      • Speaker: Elizabeth K. Van Dril, Pharm.D., BCACP, BCPS, CDCES

      Pain and Palliative Care PRN Focus Session -- Safe and Effective Use of Methadone and Buprenorphine in Pain Management
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-185-L08-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Amanda L. Engle, Pharm.D.

        Assistant Professor and Director of Interprofessional Education, Albany College of Pharmacy and Health Sciences, Albany, New York

      Learning Objectives
      1. Describe best practices in pharmacotherapy of methadone and buprenorphine use in pain management.
      2. Recall the unique pharmacology, pharmacokinetics, and pharmacodynamics of methadone and buprenorphine.
      3. Discuss methadone and buprenorphine in comparison to other opioid agonists.
      4. Identify significant drug interactions, safety concerns, and special patient populations that warrant special consideration for methadone and buprenorphine use.

      Safe and Effective Use of Methadone in Pain Management
      • Speaker: Jeffrey J. Bettinger, Pharm.D.
        Clinical Pharmacist Specialist, Pain Management Saratoga Hospital Medical Group

      Safe and Effective Use of Buprenorphine in Pain Management
      • Speaker: Olivia Caron, Pharm.D., BCACP

        Clinical Pharmacist, Moutain Area Health Education Center (MAHEC) Department of Pharmacotherapy
        Director of Research, MAHEC Project CARA
        Assistant Professor of Clinical Education, UNC-Chapel Hill Eshelman School of Pharmacy

      • Speaker: Gwen Seamon, Pharm.D., BCACP

        Ambulatory Care Clinical Pharmacist

        St. Elizabeth Healthcare, Edgewood, Kentucky

      Geriatrics PRN Focus Session -- Being the Bridge to Optimizing Medication Management in Older Adults Across the Care Continuum
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-186-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Stephanie M. Crist, Pharm.D., BCGP

        Clinical Pharmacist Specialist with Mercy St. Louis and Senior Care Consultant in Missouri

      Learning Objectives
      1. Explain barriers to comprehensive medication therapy management in older adults.
      2. Highlight a clinical pharmacist’s role in deprescribing in post-acute and long-term care transitions.
      3. Discuss approaches to optimizing appropriate prescribing across the post-acute care and long-term care continuum.
      4. Distinguish current versus future geriatric practice models that target barriers to comprehensive medication management in older adults.
      5. Recognize opportunities a clinical pharmacist can implement in post-actute services for comprehensive medication management.
      6. Review interprofessional team strategies to aid at improving medication misadventures in older adults.

      Don’t be the Gate: Approaches to Overcome Medication Management Barriers that Hold Back Older Adults
      • Speaker: Tesfahun Eshetie, Ph.D.
        Research Fellow, Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute (SAHMRI).
        Adjunct Research Fellow, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia. 

      The Golden Years Ahead: Navigating the Post-Acute Care Continuum with Future Practice Advancement
      • Speaker: Kalin M. Clifford, Pharm.D., BCGP, BCPS
        Associate Professor, Division of Geriatrics and Pediatrics
        Department of Pharmacy Practice
        TTUHSC Jerry H. Hodge School of Pharmacy
        Dallas, Texas

      Global Clinical Pharmacy Innovations
      October 18, 2022 1:15 PM

      Activity No. 0217-0000-22-183-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Alan H. Lau, Pharm.D.
        Professor and Director, International Clinical Pharmacy Education, University of Illinois Chicago College of Pharmacy, Chicago, Illinois
      Learning Objectives
      1. Recall a brief history of similar clinical pharmacy innovations in Asia and the Middle East.
      2. Describe the resources required to promote this clinical innovation in each country/region.
      3. Explain why the activities described are unique or innovative within each country/region.
      4. Discuss how each activity addresses quality improvement.
      5. Describe each activity’s impact on patient outcomes.

      Promoting Health Equity: Transforming Pharmacy Practice in a Community-Based Medical Social Transdisciplinary Care Model
      • Speaker: Janet Kit-ting Wong, BCCP

        Lecturer, Department of Pharmacology and Pharmacy, The University of Hong Kong; Consultant Pharmacist, Health In Action, Hong Kong S.A.R.

      Multidisciplinary Kidney Care Team Involving Renal Pharmacists
      • Speaker: Weerachai Chaijamorn

        Associate Professor

        Faculty of Pharmacy, Siam University, Bangkok, Thailand

      Global Contributions of Pharmacists During the COVID-19 Pandemic
      • Speaker: Debra A. Goff, Pharm.D., FCCP

        Specialty Practice Pharmacist Infectious Diseases, The Ohio State University Wexner Medical Center;  Professor of Pharmacy Practice, OSU College of Pharmacy, Columbus, Ohio

      Clinical Pharmacy Education in Turkey
      • Speaker: Aysu Selcuk, Ph.D.

        Lecturer, Ankara University Faculty of Pharmacy Department of Clinical Pharmacy, Turkey

      Imposters, Negotiators, Mentors, & Perfectionists: A Journey to Confident Leadership
      October 18, 2022 3:00 PM

      Activity No. 0217-0000-22-227-L04-P; 2.00 contact hours.
      Application Based Activity

      • Speaker: Debbie C. Byrd, Pharm.D.

        Dean and Professor, Bill Gatton College of Pharmacy and Interim Dean, College of Nursing

        East Tennessee State University, Johnson City, Tennessee

      Learning Objectives
      1. Describe the imposter syndrome.
      2. Adopt a successful negotiation philosophy.
      3. Identify strategies to attract mentors.
      4. Describe some negative aspects of perfectionism.
      Best Practices for Caring for Patients on Race and Genetic Modifiers for Medication Management
      October 18, 2022 3:00 PM

      Activity No. 0217-0000-22-189-L01-P; 1.50 contact hours.
      Application Based Activity

      • Moderator: Rebecca Cope, Pharm.D., MPH

        Associate Professor of Pharmacy Practice

        Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University 

      Learning Objectives
      1. Define race-based medicine and summarize the historical context and rationale for the use of race in medicine.
      2. Describe the benefits and risks of using race-based clinical algorithms.
      3. Use best practices for relaying information and involving the patient in decision-making processes related to race, ethnicity, or precision medicine.
      4. Describe the guidelines, evidence, and rationale outlining the use of race-based algorithms in cardiovascular medicine.
      5. Illustrate the appropriate use of race-based data and clinical guideline recommendations for cardiovascular disease states.
      6. Describe the controversies around the use of race-based medicine in cardiovascular medicine and implications for clinical practice.
      7. Describe the guidelines, evidence, and rationale outlining the use of race-based algorithms in kidney diseases.
      8. Illustrate the appropriate use of race-based data and clinical guideline recommendations for kidney diseases.
      9. Describe the controversies around the use of race-based medicine in kidney diseases and implications for clinical practice.

      Race-Based Medicine: Where Does it Come From and What is the Danger?
      • Speaker: Jasmine Luzum, Pharm.D., Ph.D.

        Assistant Professor, University of Michigan College of Pharmacy

      Getting to the Heart of the Matter: Race-Based Medicine in Cardiovascular Disease
      • Speaker: Sarah L. Anderson, Pharm.D., FCCP, BCACP

        Scientific Director, Clinical Care Options

        Denver, Colorado

      Rebalancing the Equation: (Re) Appropriating Race-Based Modifiers in Kidney Disease
      • Speaker: Wendy L. St. Peter, Pharm.D., FCCP

        Professor
        University of Minnesota – College of Pharmacy
        Minneapolis, Minnesota

      Drug Information PRN Focus Session – Combatting an Infodemic in a Digital Age
      October 18, 2022 3:00 PM

      Activity No. 0217-0000-22-190-L04-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: Jamie N. Brown, Pharm.D., FCCP, BCACP, BCPS
        PGY2 Medication-Use Safety and Policy Residency Program Director Drug Information/Investigational Drug Service Program Manager Durham VA Health Care System, Durham, North Carolina
      Learning Objectives
      1. Define infodemic and health literacy.
      2. Describe the impact that health literacy has on medical knowledge.
      3. Discuss the current state of medical misinformation on social media.
      4. Identify examples of medical misinformation.
      5. Outline possible solutions to combat medical misinformation.

      Infodemic Pandemic and Health Literacy
      • Speaker: Jason Isch, Pharm.D., BCACP

        Assistant Professor of Pharmacy Practice, Manchester University
        Ambulatory Care Clinical Pharmacist, Saint Joseph Health System
        South Bend, Indiana

      Medical Information in a Social Media Age
      • Speaker: Sierra Richard, Pharm.D., BCPPS

        Clinical Pharmacist Specialist-Investigational Drugs

        Univeristy of Missouri Health Care

      Medical Misinformation – What Should You Do?
      • Speaker: Jennifer Phillips, Pharm.D., FCCP, BCPS
        Assistant Professor, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois

      Perioperative Care PRN Focus Session -- From the Operation Room to the Intensive Care Unit: Gadgets, Gases, and Guidance for Safe Use
      October 18, 2022 3:00 PM

      Activity No. 0217-0000-22-191-L05-P; 1.50 contact hours.
      Knowledge Based Activity

      • Moderator: William R. Vincent, III, Pharm.D., BCCCP
        Clinical Pharmacy Coordinator – Surgery
        Boston Medical Center
        Boston, Massachusetts
      Learning Objectives
      1. Review literature supporting the use of volatile anesthetics in non-operative settings.
      2. Describe ideal candidates and monitoring necessary for use of volatile anesthetics in an ICU setting.
      3. Summarize the performance characteristics and potential uses of novel intraoperative monitoring technologies in critically ill patients.
      4. Discuss bispectral index and non-invasive hemodynamic monitoring and its application to the management of sedation and vasopressory therapy, respectively.
      5. Explain key practices identified by the ISMP self-assessment that can be applied in the perioperative setting.
      6. Identify strategies to leverage pharmacist involvement in promoting medication safety in the perioperative setting.

      Utilization of Volatile Anesthetics Outside of the Operating Room
      • Speaker: Christine Ji, Pharm.D., BCCP, BCPS

        Clinical Pharmacy Coordinator - Cardiology, Cardiac Critical Care

        Massachusetts General Hospital, Boston MA

      Application of Medication Monitoring Technology to the Critically Ill
      • Speaker: Patrick M. Wieruszewski, Pharm.D., BCCCP

        Assistant Professor of Anesthesiology

        Assistant Professor of Pharmacy

        Mayo Clinic

      Perioperative Medication Safety Best Practices
      • Speaker: Andrea DiPietro, Pharm.D.

        Director, Clinical Strategy & Operations

        Bainbridge Health, Philadelphia PA

      Adjusting for Success in Teaching, Learning, and Development
      October 18, 2022 3:15 PM

      Activity No. 0217-0000-22-220-L04-P; 2.00 contact hours.
      Application Based Activity

      • Speaker: Daniel S. Longyhore, Pharm.D., FCCP, BCACP

        System Director for Knowledge Management, Geisinger, Enterprise Pharmacy

      Learning Objectives
      1. Review formative assessment practices to foster success in learning and development.
      2. Determine the appropriateness of individualized development activities to assist in meetings professional outcomes, standards, and competencies.
      3. Discuss self-assessment and reflection as a learning and professional development tool.

        Back to Global Conference
      Dedicated to Excellence in Clinical Pharmacy Practice, Research, and Education
      © American College of Clinical Pharmacy
      World Headquarters
      13000 W 87th St. Pkwy
      Lenexa, KS 66215-4530
      (913) 492-3311
      www.accp.com
      Washington Office
      1455 Pennsylvania Ave., NW
      Suite 400
      Washington, DC 20004-1017
      (202) 621-1820
      Other Links
      Related Sites